{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/cg7b01443.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>We\nhave synthesized a novel family of metal\u2013organic chains\nbased on 4-nitro-1<italic>H</italic>-pyrazole linker and zinc as metal\ncenter. We report the formation of these coordination polymers using\nhydrothermal routes with water as solvent. These materials display\none-dimensional structures with major structural modifications from\nminimal synthetic variations. What is more interesting, we have carried\nout antitumor measurements, and we have related these properties with\nthe structural networks. To the best of our knowledge, these materials\nconstitute the first examples of polymeric structures for 4-NO<sub>2</sub>-pz ligands. NMR and MS spectrometry were used to verify the\ncharacterization of the metal complexes in solution to corroborate\nthat these materials are present in the biological assays.</p>", "clean_text": "We have synthesized a novel family of metal-organic chains based on 4-nitro-1H-pyrazole linker and zinc as metal center. We report the formation of these coordination polymers using hydrothermal routes with water as solvent. These materials display one-dimensional structures with major structural modifications from minimal synthetic variations. What is more interesting, we have carried out antitumor measurements, and we have related these properties with the structural networks. To the best of our knowledge, these materials constitute the first examples of polymeric structures for 4-NO2-pz ligands. NMR and MS spectrometry were used to verify the characterization of the metal complexes in solution to corroborate that these materials are present in the biological assays.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<p>We have synthesized a novel family of metal\u2212organic\nchains based on 4-nitro-1<italic>H</italic>-pyrazole and zinc as metal\ncenter. These materials display one-dimensional structures with structural\nmodifications from minimal synthetic variations. What is more interesting,\nwe have related antitumor properties with the structural networks.\nTo the best of our knowledge, these materials constitute the first\nexamples of polymeric structures for 4-NO2-pz ligands.</p>", "clean_text": "We have synthesized a novel family of metal-organic chains based on 4-nitro-1H-pyrazole and zinc as metal center. These materials display one-dimensional structures with structural modifications from minimal synthetic variations. What is more interesting, we have related antitumor properties with the structural networks. To the best of our knowledge, these materials constitute the first examples of polymeric structures for 4-NO2-pz ligands.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Since the discovery\nof coordination polymers (CPs), these materials\nhave been intensively studied due to their potential applications\nin areas such as luminescence, gas adsorption, optical storage, magnetism, and biology as drug-delivery systems or cytotoxic agents. Within these systems we could consider metal\u2013organic chains\n(MOCs) as 1D-coordination polymers in which the combination of metal\ncenters and organic ligands provides fantastic possibilities for the\nconstruction of materials with various structures and functionalities. In this sense, we and others have synthesized a large variety of\ncoordination compounds based on triazolopyrimidine ligands with interesting\nbiological properties. In particular, the study of these\ncoordination compounds as antitumor materials has not been enough\nexplored so far, though these systems with cheap and nontoxic metal\ncenters can be essential in many biological processes. For these reasons,\nwe decided to synthesize new MOCs by using zinc as metal ion in order\nto study some of the anticancer properties or activity exhibited by\nthese materials. On another level, we selected 4-nitro-1<italic>H</italic>-pyrazole (\u03bc-4-NO<sub>2</sub>-Hpz) as ligand, a scarcely explored molecule for CPs construction, given\nits potential capacity to fulfill the above-mentioned structural and\nbiological roles. Regarding its coordinating ability in metal\u2013organic\narchitectures, pyrazole based and related N-donor aromatic ligands\nsuch as tetrazole constitute a well-established class of connectors\nthat, combined with metal ions that render tetrahedral geometries,\ngive rise to CPs with high thermal and chemical stability. Especially, those frameworks with zeolitic topologies\nare to be highlighted. The relative <italic>ortho</italic>-disposition of the donor nitrogen atoms in the pyrazole ring gives\nthis ditopic ligand the opportunity to show two possible coordination\nmodes () according\nto its neutral or anionic nature. Despite its preference to act as\na ditopic bridging linker by adopting coordination mode <italic>b</italic>, it is worth noticing the lack of polymeric architectures for this\nligand among the scarce structural diversity governed by isolated\ncomplexes and metallacycles. As a consequence, we\ndecided to exploit this interesting ligand as a potential linker to\nconstruct novel zinc-based MOCs.</p>", "clean_text": "Introduction\n\nSince the discovery of coordination polymers (CPs), these materials have been intensively studied due to their potential applications in areas such as luminescence, gas adsorption, optical storage, magnetism, and biology as drug-delivery systems or cytotoxic agents. Within these systems we could consider metal-organic chains (MOCs) as 1D-coordination polymers in which the combination of metal centers and organic ligands provides fantastic possibilities for the construction of materials with various structures and functionalities. In this sense, we and others have synthesized a large variety of coordination compounds based on triazolopyrimidine ligands with interesting biological properties. In particular, the study of these coordination compounds as antitumor materials has not been enough explored so far, though these systems with cheap and nontoxic metal centers can be essential in many biological processes. For these reasons, we decided to synthesize new MOCs by using zinc as metal ion in order to study some of the anticancer properties or activity exhibited by these materials. On another level, we selected 4-nitro-1H-pyrazole (\u03bc-4-NO2-Hpz) as ligand, a scarcely explored molecule for CPs construction, given its potential capacity to fulfill the above-mentioned structural and biological roles. Regarding its coordinating ability in metal-organic architectures, pyrazole based and related N-donor aromatic ligands such as tetrazole constitute a well-established class of connectors that, combined with metal ions that render tetrahedral geometries, give rise to CPs with high thermal and chemical stability. Especially, those frameworks with zeolitic topologies are to be highlighted. The relative ortho-disposition of the donor nitrogen atoms in the pyrazole ring gives this ditopic ligand the opportunity to show two possible coordination modes () according to its neutral or anionic nature. Despite its preference to act as a ditopic bridging linker by adopting coordination mode b, it is worth noticing the lack of polymeric architectures for this ligand among the scarce structural diversity governed by isolated complexes and metallacycles. As a consequence, we decided to exploit this interesting ligand as a potential linker to construct novel zinc-based MOCs.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"schI\" position=\"float\">\n<label>1</label>\n<caption>\n<title>4-Nitro-1<italic>H</italic>-pyrazole\n(Left) and the Two Different\nCoordination Modes Presented by This Linker (Right: Modes <italic>a</italic> and <italic>b</italic>)</title>\n</caption>\n<graphic id=\"GRAPHIC-d7e405-autogenerated\" position=\"float\" xlink:href=\"cg-2017-01443m_0010.tif\"></graphic>\n</fig>", "clean_text": " 1  4-Nitro-1H-pyrazole (Left) and the Two Different Coordination Modes Presented by This Linker (Right: Modes a and b)   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>The biological interest for complexes containing nitro substituted\nligands, such as the deeply explored nitroimidazole based complexes, originates from their proven ability to mark hypoxic (oxygen deficient)\ncell regions, which are characteristic of solid tumors. In this sense, the slow metabolism of the nitro compounds and their\nability to diffuse through nonvascular cell masses allow deep penetration,\nmaking them effective tools for marking the hypoxic cells. Moreover,\nthese kinds of ligands may act as radiosensitizers owing to the electron\naffinity of the nitro group by dioxygen molecule, thus allowing drugs\nrequiring dioxygen to be more effective.\n</p>", "clean_text": "The biological interest for complexes containing nitro substituted ligands, such as the deeply explored nitroimidazole based complexes, originates from their proven ability to mark hypoxic (oxygen deficient) cell regions, which are characteristic of solid tumors. In this sense, the slow metabolism of the nitro compounds and their ability to diffuse through nonvascular cell masses allow deep penetration, making them effective tools for marking the hypoxic cells. Moreover, these kinds of ligands may act as radiosensitizers owing to the electron affinity of the nitro group by dioxygen molecule, thus allowing drugs requiring dioxygen to be more effective. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>Bearing in mind the interest of our groups in the study of\nthe\ncytotoxic anticancer properties of metal\u2013organic chains and\nfunctionalized nanomaterials, we decided to study\nthe cytotoxic properties of these novels Zn-MOCs, which were prepared\nfrom 4-NO<sub>2</sub>-pz as ligand to establish a connection between\nstructural properties and anticancer potential.</p>", "clean_text": "Bearing in mind the interest of our groups in the study of the cytotoxic anticancer properties of metal-organic chains and functionalized nanomaterials, we decided to study the cytotoxic properties of these novels Zn-MOCs, which were prepared from 4-NO2-pz as ligand to establish a connection between structural properties and anticancer potential.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>Given that currently\nmajor commercially anticancer drugs exhibit\nlow therapeutics efficacy due their inability to accumulate preferentially\nin tumor tissues, and therefore are administrated\nat high doses in order to compensate for nonideal biodistribution,\nwhich can lead to serious adverse effects, it is of great interest to search new drugs that can fight this\ndisease effectively with minimal side effects. In this sense, the\nuse of coordination polymers as promising chemotherapeutics anticancer\nagents has been recently reported. These new compounds exhibit several beneficial effects\nthat improve their use as anticancer drugs, as for example they have\na high half-life to allow their preferential tumor accumulation, due\nto their highest vascular permeability that permits their retention\non tumor tissues. In this sense, we explored\nZn-pyrazole complexes in order to enhance particle stability and reduce\ntoxicity.</p>", "clean_text": "Given that currently major commercially anticancer drugs exhibit low therapeutics efficacy due their inability to accumulate preferentially in tumor tissues, and therefore are administrated at high doses in order to compensate for nonideal biodistribution, which can lead to serious adverse effects, it is of great interest to search new drugs that can fight this disease effectively with minimal side effects. In this sense, the use of coordination polymers as promising chemotherapeutics anticancer agents has been recently reported. These new compounds exhibit several beneficial effects that improve their use as anticancer drugs, as for example they have a high half-life to allow their preferential tumor accumulation, due to their highest vascular permeability that permits their retention on tumor tissues. In this sense, we explored Zn-pyrazole complexes in order to enhance particle stability and reduce toxicity.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<p>Our main objective has been to search new compounds\nwith high cytotoxicity\nand antitumor properties with biocompatible metal ions providing minimal\nside effects. In this article, we studied the anticancer effects of\nthree Zn-MOCs coordination complexes. Their cytotoxicity properties\nhave been assayed on three different cancer cell lines, HT29 (colon\ncancer cells), Hep-G2 (hepatoma cells), and B16-F10 (melanoma cells).</p>", "clean_text": "Our main objective has been to search new compounds with high cytotoxicity and antitumor properties with biocompatible metal ions providing minimal side effects. In this article, we studied the anticancer effects of three Zn-MOCs coordination complexes. Their cytotoxicity properties have been assayed on three different cancer cell lines, HT29 (colon cancer cells), Hep-G2 (hepatoma cells), and B16-F10 (melanoma cells).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<p>MOCs properties offer a new approach to new anticancer drug development,\nachieving less side effects and selective drugs delivery that could\ndirectly benefit cancer patients.</p><p>In summary, we report herein\nthe synthesis, structure, and antitumor\nproperties of (4-NO<sub>2</sub>-Hpz)<sub>4</sub> (<bold>1</bold>),\n{[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>3</sub>(\u03bc-OH)]\u00b7H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub> (<bold>2</bold>), {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>3</bold>), and {[Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>(\u03bc-ac)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>4</bold>), demonstrating the\npotential of this pyrazolate linker to construct new MOCs with interesting\nphysical and biological properties. Moreover, a remarkable structural\nfeature of these compounds is the occurrence of one-dimensional arrays,\nwhich constitute the first examples of polymeric structures for 4-NO<sub>2</sub>-pz ligands.</p>", "clean_text": "MOCs properties offer a new approach to new anticancer drug development, achieving less side effects and selective drugs delivery that could directly benefit cancer patients.\n\nIn summary, we report herein the synthesis, structure, and antitumor properties of (4-NO2-Hpz)4 (1), {[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n  (2), {[Zn2(\u03bc-4-NO2-pz)4]} n  (3), and {[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n  (4), demonstrating the potential of this pyrazolate linker to construct new MOCs with interesting physical and biological properties. Moreover, a remarkable structural feature of these compounds is the occurrence of one-dimensional arrays, which constitute the first examples of polymeric structures for 4-NO2-pz ligands.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<title>Experimental Procedures</title><title>Materials\nand Physical Measurements</title><p>All reagents were\nobtained from commercial sources and used as received. Elemental (C,\nH, and N) analyses were performed on a Leco CHNS-932 microanalyzer.\nIR spectra of powdered samples were recorded in the 400\u20134000\ncm<sup>\u20131</sup> region on a Nicolet 6700 FTIR spectrophotometer\nusing KBr pellets.</p>", "clean_text": "Experimental Procedures\n\nMaterials and Physical Measurements\n\nAll reagents were obtained from commercial sources and used as received. Elemental (C, H, and N) analyses were performed on a Leco CHNS-932 microanalyzer. IR spectra of powdered samples were recorded in the 400-4000 cm-1 region on a Nicolet 6700 FTIR spectrophotometer using KBr pellets.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>3</sub>(\u03bc-OH)]\u00b7H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub> (<bold>2</bold>)</title><p>Compound <bold>2</bold> was obtained by\nhydrothermal routes through the following procedure: A mixture of\nZnCl<sub>2</sub> (0.068 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole\n(0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 43%, based on Zn.\nAnal. Calcd C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub>: C 21.53, H 1.81, N 25.11. Found: C 21.42, H 1.76, N 25.32.</p>", "clean_text": "Synthesis of {[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n  (2)\n\nCompound 2 was obtained by hydrothermal routes through the following procedure: A mixture of ZnCl2 (0.068 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 43%, based on Zn. Anal. Calcd C9H9N9O8Zn2: C 21.53, H 1.81, N 25.11. Found: C 21.42, H 1.76, N 25.32.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 12, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>3</bold>)</title><p>A mixture\nof Zn\u00ad(NO<sub>3</sub>)<sub>2</sub>\u00b76\u00ad(H<sub>2</sub>O)\n(0.149 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole (0.113 g,\n1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 55%, based on Zn.\nAnal. Calcd C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub>: C 24.89, H 1.39, N 29.03. Found: C 24.69, H 1.31,\nN 29.24.</p>", "clean_text": "Synthesis of {[Zn2(\u03bc-4-NO2-pz)4]} n  (3)\n\nA mixture of Zn(NO3)2\u22c56(H2O) (0.149 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 55%, based on Zn. Anal. Calcd C12H8N12O8Zn2: C 24.89, H 1.39, N 29.03. Found: C 24.69, H 1.31, N 29.24.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 13, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of {[Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>(\u03bc-ac)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>4</bold>)</title><p>A mixture of zinc\nacetate (0.092 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole\n(0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 37%, based on Zn.\nAnal. Calcd C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub>: C 24.06, H 2.27, N 21.05. Found: C 23.96, H 2.21,\nN 21.19.</p>", "clean_text": "Synthesis of {[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n  (4)\n\nA mixture of zinc acetate (0.092 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 37%, based on Zn. Anal. Calcd C16H18N12O14Zn3: C 24.06, H 2.27, N 21.05. Found: C 23.96, H 2.21, N 21.19.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<title>Crystallographic Refinement and Structure\nSolution</title><p>Prismatic crystals for <bold>1</bold>\u2013<bold>4</bold> were\nmounted on a glass fiber and used for data collection on a Bruker\nD8 Venture with Photon detector equipped with graphite monochromated\nMoK\u03b1 radiation (\u03bb = 0.71073 \u00c5). The data reduction\nwas performed with the APEX2 software\nand corrected for absorption using SADABS. Crystal structures were solved by direct methods using the SIR97\nprogram and refined by full-matrix least-squares\non <italic>F</italic>\n<sup>2</sup> including all reflections using\nanisotropic displacement parameters by means of the WINGX crystallographic\npackage that provide a graphical user interface for other crystallographic\nprograms, in particular for SHELXL.\n</p>", "clean_text": "Crystallographic Refinement and Structure Solution\n\nPrismatic crystals for 1-4 were mounted on a glass fiber and used for data collection on a Bruker D8 Venture with Photon detector equipped with graphite monochromated MoK\u03b1 radiation (\u03bb = 0.71073 \u00c5). The data reduction was performed with the APEX2 software and corrected for absorption using SADABS. Crystal structures were solved by direct methods using the SIR97 program and refined by full-matrix least-squares on F 2 including all reflections using anisotropic displacement parameters by means of the WINGX crystallographic package that provide a graphical user interface for other crystallographic programs, in particular for SHELXL. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "text", "classification": ["else"], "content": "<p>Generally,\nanisotropic temperature factors were assigned to all atoms except\nfor hydrogen atoms, which are riding their parent atoms with an isotropic\ntemperature factor arbitrarily chosen as 1.2 times that of the respective\nparent. Final <italic>R</italic>(<italic>F</italic>), <italic>w</italic>\n<italic>R</italic>(<italic>F</italic>\n<sup>2</sup>), and goodness\nof fit agreement factors, details on the data collection, and analysis\ncan be found in .</p>", "clean_text": "Generally, anisotropic temperature factors were assigned to all atoms except for hydrogen atoms, which are riding their parent atoms with an isotropic temperature factor arbitrarily chosen as 1.2 times that of the respective parent. Final R(F), w R(F 2), and goodness of fit agreement factors, details on the data collection, and analysis can be found in .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 16, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data for Compounds <bold>1\u20134</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>chem formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>3</sub>N<sub>3</sub>O<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC\nnumber</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514767\">1514767</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514768\">1514768</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514769\">1514769</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514766\">1514766</ext-link>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>M</italic> (g\nmol<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>113.08</oasis:entry>\n<oasis:entry>501.99</oasis:entry>\n<oasis:entry>579.04</oasis:entry>\n<oasis:entry>798.53</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>T</italic> (K)</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst syst</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic>P</italic>2<sub>1</sub>/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.0288(16)</oasis:entry>\n<oasis:entry>7.2679(3)</oasis:entry>\n<oasis:entry>9.2248(4)</oasis:entry>\n<oasis:entry>18.446(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.6212(19)</oasis:entry>\n<oasis:entry>23.1699(10)</oasis:entry>\n<oasis:entry>10.0991(4)</oasis:entry>\n<oasis:entry>13.740(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.906(2)</oasis:entry>\n<oasis:entry>9.9116(4)</oasis:entry>\n<oasis:entry>11.4626(4)</oasis:entry>\n<oasis:entry>10.814(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>74.395(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>79.557(1)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>81.549(3)</oasis:entry>\n<oasis:entry>92.337(2)</oasis:entry>\n<oasis:entry>66.699(1)</oasis:entry>\n<oasis:entry>109.872(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c3 (deg)</oasis:entry>\n<oasis:entry>83.255(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>87.241(1)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>726.5(3)</oasis:entry>\n<oasis:entry>1667.69(12)</oasis:entry>\n<oasis:entry>964.21(7)</oasis:entry>\n<oasis:entry>2577.6(17)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Z</oasis:entry>\n<oasis:entry>6</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1 (g cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.551</oasis:entry>\n<oasis:entry>1.999</oasis:entry>\n<oasis:entry>1.994</oasis:entry>\n<oasis:entry>2.058</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>0.132</oasis:entry>\n<oasis:entry>2.942</oasis:entry>\n<oasis:entry>2.563</oasis:entry>\n<oasis:entry>2.866</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>unique reflections</oasis:entry>\n<oasis:entry>2698</oasis:entry>\n<oasis:entry>45276</oasis:entry>\n<oasis:entry>22084</oasis:entry>\n<oasis:entry>8194</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>(int)</oasis:entry>\n<oasis:entry>0.023</oasis:entry>\n<oasis:entry>0.079</oasis:entry>\n<oasis:entry>0.043</oasis:entry>\n<oasis:entry>0.032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.060</oasis:entry>\n<oasis:entry>1.067</oasis:entry>\n<oasis:entry>1.034</oasis:entry>\n<oasis:entry>1.069</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>1\u00a0[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.054</oasis:entry>\n<oasis:entry>0.034</oasis:entry>\n<oasis:entry>0.028</oasis:entry>\n<oasis:entry>0.032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>2\u00a0[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.132</oasis:entry>\n<oasis:entry>0.062</oasis:entry>\n<oasis:entry>0.058</oasis:entry>\n<oasis:entry>0.074</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>(<italic>F</italic>) = \u2211||<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>||/\u2211|<italic>F</italic>\n<sub>o</sub>|; <italic>wR</italic>(<italic>F</italic>\n<sup>2</sup>) = [\u2211<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic>wF</italic>\n<sup>4</sup>]<sup>1/2</sup>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "text", "classification": ["else"], "content": "<title>Solution NMR Studies</title><p>Solution NMR spectra were recorded\nusing a Bruker Avance III spectrometer instrument operating at 1H\nLarmor frequency of 300 MHz and are referenced according to IUPAC\nrecommendation, with <sup>1</sup>H and <sup>13</sup>C chemical shifts\nrelative to TMS.</p>", "clean_text": "Solution NMR Studies\n\nSolution NMR spectra were recorded using a Bruker Avance III spectrometer instrument operating at 1H Larmor frequency of 300 MHz and are referenced according to IUPAC recommendation, with 1H and 13C chemical shifts relative to TMS.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 18, "type": "text", "classification": ["else"], "content": "<p>NMR sample preparation: Compounds <bold>3</bold> and <bold>4</bold> were each of one placed in a J-Young NMR tube,\nwhich were connected to a vacuum/N<sub>2</sub> line and evacuated\nby three N<sub>2</sub>/vacuum cycles. Then, 0.4 mL of anhydrous DMSO-<italic>d</italic>\n<sub>6</sub> (dried over activated 4 \u00c5 molecular sieves\nfor 24 h) were added to each sample. Each NMR tube was then inserted\ninto the bore of the magnet, and standard one-dimensional (<sup>1</sup>H, <sup>13</sup>C, and DEPT-135) and two-dimensional (HMQC and HMBC)\nexperiments were acquired.</p>", "clean_text": "NMR sample preparation: Compounds 3 and 4 were each of one placed in a J-Young NMR tube, which were connected to a vacuum/N2 line and evacuated by three N2/vacuum cycles. Then, 0.4 mL of anhydrous DMSO-d 6 (dried over activated 4 \u00c5 molecular sieves for 24 h) were added to each sample. Each NMR tube was then inserted into the bore of the magnet, and standard one-dimensional (1H, 13C, and DEPT-135) and two-dimensional (HMQC and HMBC) experiments were acquired.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<title>Drugs</title><p>The different compounds used\nin cell treatment\nwere dissolved before use at 5 mg/mL in DMSO. A stock solution was\nfrozen and stored at 4 \u00b0C. Prior to the experiments, this solution\nwas diluted in cell-culture medium. All the experiments were measured\nand compared to the controls after 72 h of treatment.</p>", "clean_text": "Drugs\n\nThe different compounds used in cell treatment were dissolved before use at 5 mg/mL in DMSO. A stock solution was frozen and stored at 4 \u00b0C. Prior to the experiments, this solution was diluted in cell-culture medium. All the experiments were measured and compared to the controls after 72 h of treatment.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 20, "type": "text", "classification": ["else"], "content": "<title>Cell Culture</title><p>Human colorectal adenocarcinoma cell line\nHT29 (ECACC no. 9172201; ATCC no. HTB-38), human hepatocarcinome cell\nline Hep G2 (ECACC no. 85011430), and mouse melanoma cells B16-F10\n(ATCC no. CRL-6475) were cultured in DMEM supplemented with 2 mM glutamine,\n10% heat-inactivated FBS, 10,000 units/mL of penicillin, and 10 mg/mL\nof streptomycin, being incubated at 37 \u00b0C in an atmosphere of\n5% CO<sub>2</sub> and 95% humidity. Subconfluent monolayer cells were\nused in all experiments.</p>", "clean_text": "Cell Culture\n\nHuman colorectal adenocarcinoma cell line HT29 (ECACC no. 9172201; ATCC no. HTB-38), human hepatocarcinome cell line Hep G2 (ECACC no. 85011430), and mouse melanoma cells B16-F10 (ATCC no. CRL-6475) were cultured in DMEM supplemented with 2 mM glutamine, 10% heat-inactivated FBS, 10,000 units/mL of penicillin, and 10 mg/mL of streptomycin, being incubated at 37 \u00b0C in an atmosphere of 5% CO2 and 95% humidity. Subconfluent monolayer cells were used in all experiments.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<p>All cell lines used were provided by\nthe cell bank of the University of Granada, Spain. B16-F10 cells were\nderived from a melanoma from the skin of a C57BL/6 strain mouse are\nadherent cells with fibroblast-like appearance, capable of producing\nmelanin, and form metastatic tumor nodules in lung by injecting in\nmice. The clon F10 of B16 cells is susceptible\nto lysis mediated by syngeneic lymphocytes. HT29 cells were isolated from a colon cancer of a 44 years old Caucasian\nfemale, have tumorogenic capacity shown in nude mice, and produce\nwell-differentiated adenocarcinoma, consistent with colon primary\nadenocarcinome (grade I). This cell line is positive for the expression\nof myc+, ras+, myb+, fos+, p53+, abl\u2013, ros\u2013, and src\u2013\n(ATCC: HTB-38). Doubling time is around 48 h in normal culture conditions.\nHep G2 cells were isolated from a liver biopsy of a male Caucasian\naged 15 years and consistent with a well-differentiated hepatocellular\ncarcinoma. This cell line not is tumorogenic, and there is not evidence\nof a Hepatitis B virus genome in this cell line.</p>", "clean_text": "All cell lines used were provided by the cell bank of the University of Granada, Spain. B16-F10 cells were derived from a melanoma from the skin of a C57BL/6 strain mouse are adherent cells with fibroblast-like appearance, capable of producing melanin, and form metastatic tumor nodules in lung by injecting in mice. The clon F10 of B16 cells is susceptible to lysis mediated by syngeneic lymphocytes. HT29 cells were isolated from a colon cancer of a 44 years old Caucasian female, have tumorogenic capacity shown in nude mice, and produce well-differentiated adenocarcinoma, consistent with colon primary adenocarcinome (grade I). This cell line is positive for the expression of myc+, ras+, myb+, fos+, p53+, abl-, ros-, and src- (ATCC: HTB-38). Doubling time is around 48 h in normal culture conditions. Hep G2 cells were isolated from a liver biopsy of a male Caucasian aged 15 years and consistent with a well-differentiated hepatocellular carcinoma. This cell line not is tumorogenic, and there is not evidence of a Hepatitis B virus genome in this cell line.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 22, "type": "text", "classification": ["else"], "content": "<title>Cell-Proliferation\nActivity Assay</title><p>The cell proliferation\neffect after treatment with compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, or <bold>4</bold> in B16-F10 murine melanoma cells,\nHT29 colon carcinoma cells, and Hep G2 hepatocarcinoma cells was measured\nusing the MTT assay (Sigma, MO, USA), which is based on the ability\nof live cells to cleave the tetrazolium ring, thus producing formazan,\nwhich absorbs at 570 nm.</p>", "clean_text": "Cell-Proliferation Activity Assay\n\nThe cell proliferation effect after treatment with compounds 1, 2, 3, or 4 in B16-F10 murine melanoma cells, HT29 colon carcinoma cells, and Hep G2 hepatocarcinoma cells was measured using the MTT assay (Sigma, MO, USA), which is based on the ability of live cells to cleave the tetrazolium ring, thus producing formazan, which absorbs at 570 nm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 23, "type": "text", "classification": "error", "content": "<p>Cell viability was determined by measuring\nthe absorbance of MTT dye staining of living cells. For this assay,\n5 \u00d7 10<sup>3</sup> B16-F10 cells, 6 \u00d7 10<sup>3</sup> HT29\ncells, and15 \u00d7 10<sup>3</sup> Hep G2 cells were grown on a 96-well\nplate and incubated with different concentrations of compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> (0\u2013100\n\u03bcg/mL). Lately, after 72 h of incubation, 100 \u03bcL of MTT\nsolution (0.5 mg/mL) was added to each well. After 1.5 h of incubation,\nthe cells were washed twice with PBS, and formazan was resuspended\nin 100 \u03bcL of DMSO. Relative cell viability, with respect to\nuntreated control cells, was measured by absorbance at 550 nm on an\nELISA plate reader (Tecan Sunrise MR20-301, TECAN, Austria).</p>", "clean_text": "Cell viability was determined by measuring the absorbance of MTT dye staining of living cells. For this assay, 5 \u00d7 103 B16-F10 cells, 6 \u00d7 103 HT29 cells, and15 \u00d7 103 Hep G2 cells were grown on a 96-well plate and incubated with different concentrations of compounds 1, 2, 3, and 4 (0-100 \u03bcg/mL). Lately, after 72 h of incubation, 100 \u03bcL of MTT solution (0.5 mg/mL) was added to each well. After 1.5 h of incubation, the cells were washed twice with PBS, and formazan was resuspended in 100 \u03bcL of DMSO. Relative cell viability, with respect to untreated control cells, was measured by absorbance at 550 nm on an ELISA plate reader (Tecan Sunrise MR20-301, TECAN, Austria).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<title>Statistics</title><p>Statistical and nonlineal regression analyses\nwere performed with the SigmaPlot 12.5 software. All quantitative\ndata were summarized as the means \u00b1 standard deviation (SD).\nAll data shown here were representative of at least two independent\nexperiments performed in triplicate.</p>", "clean_text": "Statistics\n\nStatistical and nonlineal regression analyses were performed with the SigmaPlot 12.5 software. All quantitative data were summarized as the means \u00b1 standard deviation (SD). All data shown here were representative of at least two independent experiments performed in triplicate.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 25, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Description\nof the Structures</title><title>Structural Description of 4-NO<sub>2</sub>-Hpz (<bold>1</bold>)</title><p>X-ray diffraction analyses of the\nligand revealed that\nit crystallizes in the neutral form in good agreement with a previous\nstructural solution reported by Llamas-Saiz et al. In the structure, there are three crystallographically\n(A, B, and C) independent 4-NO<sub>2</sub>-Hpz molecules, all of which\nare protonated at their N1 nitrogen atoms. A remarkable structural\nfeature is that the three ligands are practically planar, finding\nonly a subtle rotation for the nitro group of 0.90\u20131.74\u00b0\nwith regard to the mean aromatic ring. Three A, B, and C ligands are\ndisplayed almost coplanar to each other in such a way that they are\narranged into supramolecular trimers owing to the hydrogen bonding\nR<sup>3</sup>\n<sub>3</sub>(9) ring established from N1\u2013H\u00b7\u00b7\u00b7N2\ninteractions (). In this line, it may be assumed that each ligand acts as a hydrogen\nbonding donor and acceptor and that protons are orderly located at\nN1 atoms according to the endocyclic N\u2013N\u2013C angles established\nwithin the aromatic ring of 4-NO<sub>2</sub>-Hpz ligands.</p>", "clean_text": "Results and Discussion\n\nDescription of the Structures\n\nStructural Description of 4-NO2-Hpz (1)\n\nX-ray diffraction analyses of the ligand revealed that it crystallizes in the neutral form in good agreement with a previous structural solution reported by Llamas-Saiz et al. In the structure, there are three crystallographically (A, B, and C) independent 4-NO2-Hpz molecules, all of which are protonated at their N1 nitrogen atoms. A remarkable structural feature is that the three ligands are practically planar, finding only a subtle rotation for the nitro group of 0.90-1.74\u00b0 with regard to the mean aromatic ring. Three A, B, and C ligands are displayed almost coplanar to each other in such a way that they are arranged into supramolecular trimers owing to the hydrogen bonding R3 3(9) ring established from N1-H\u22c5\u22c5\u22c5N2 interactions (). In this line, it may be assumed that each ligand acts as a hydrogen bonding donor and acceptor and that protons are orderly located at N1 atoms according to the endocyclic N-N-C angles established within the aromatic ring of 4-NO2-Hpz ligands.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Excerpt of\nthe supramolecular layer of compound <bold>1</bold> showing\nhydrogen bonding interactions within the central trimer and with neighboring\nones. Strong N\u2013H\u00b7\u00b7\u00b7N (thick dashed orange line)\nand weak C\u2013H\u00b7\u00b7\u00b7O (thine dashed orange line)\ninteractions are drawn.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2017-01443m_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Excerpt of the supramolecular layer of compound 1 showing hydrogen bonding interactions within the central trimer and with neighboring ones. Strong N-H\u22c5\u22c5\u22c5N (thick dashed orange line) and weak C-H\u22c5\u22c5\u22c5O (thine dashed orange line) interactions are drawn.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": "error", "content": "<p>It is well-known that the protonation at N sites in similar\ncycles,\nsuch as nucleobases, does not modify substantially the bond distances,\nbut it enlarges the endocyclic C\u2013N\u2013C angles up to 4\u00b0\nas a consequence of the absence of the lone pair in those N atoms. In the present case, those angles may be compared to N\u2013N\u2013C\nangles of the pyrazole ring. In good agreement with the last argument,\na systematic enlargement of the latter angle is observed for the three\nligands [110.8 vs 107.2\u00b0 (A ligand), 110.4 vs 106.9\u00b0 (B\nligand), and 110.6 vs 107.8\u00b0 (C ligand) for C5\u2013N1\u2013N2\nand N1\u2013N2\u2013C3 angles, respectively], thus confirming\nthe location of those hydrogen atoms.</p>", "clean_text": "It is well-known that the protonation at N sites in similar cycles, such as nucleobases, does not modify substantially the bond distances, but it enlarges the endocyclic C-N-C angles up to 4\u00b0 as a consequence of the absence of the lone pair in those N atoms. In the present case, those angles may be compared to N-N-C angles of the pyrazole ring. In good agreement with the last argument, a systematic enlargement of the latter angle is observed for the three ligands [110.8 vs 107.2\u00b0 (A ligand), 110.4 vs 106.9\u00b0 (B ligand), and 110.6 vs 107.8\u00b0 (C ligand) for C5-N1-N2 and N1-N2-C3 angles, respectively], thus confirming the location of those hydrogen atoms.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 28, "type": "text", "classification": "error", "content": "<title>Structural Description\nof {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>3</sub>(\u03bc\u2013OH)]\u00b7H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub> (<bold>2</bold>)</title><p>Compound <bold>2</bold> crystallizes in the monoclinic <italic>P</italic>2<sub>1</sub>/<italic>c</italic> space group and its structure consists\nof a supramolecular\npacking of 1D double chains and lattice water molecules. The asymmetric\nunit contains two crystallographically independent zinc\u00ad(II) atoms,\nthree 4-NO<sub>2</sub>-pz ligands, a hydroxide anion, and a lattice\nwater molecule. Zn1 and Zn2 atoms show tetrahedral environments established\nfrom three pyrazole nitrogen atoms and the hydroxide oxygen atom (). Continuous shape\nmeasurements performed by SHAPE program reveal that\nboth of them exhibit a similar distortion with regard to ideal tetrahedra\n(ST of 0.88 and 0.39 for Zn1 and Zn2, respectively). Two of the three\n4-NO<sub>2</sub>-pyz ligands (A and B) act as \u03bc-\u03baN1:\u03baN2\nbridges between Zn1 and Zn2 atoms and arrange them into dimeric [Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>2</sub>] cores in which\na Zn\u00b7\u00b7\u00b7Zn distance of 3.68 \u00c5 is imposed. Hereafter,\n\u03bc-hydroxide and \u03bc-4-NO<sub>2</sub>-pz ligands (C molecules)\nemerge symmetrically from both zinc\u00ad(II) atoms in an almost perpendicular\narrangement to previous 4-NO<sub>2</sub>-pz linkers, thus joining\nadjacent dimeric cores into a one-dimensional double chain ().</p>", "clean_text": "Structural Description of {[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n  (2)\n\nCompound 2 crystallizes in the monoclinic P21/c space group and its structure consists of a supramolecular packing of 1D double chains and lattice water molecules. The asymmetric unit contains two crystallographically independent zinc(II) atoms, three 4-NO2-pz ligands, a hydroxide anion, and a lattice water molecule. Zn1 and Zn2 atoms show tetrahedral environments established from three pyrazole nitrogen atoms and the hydroxide oxygen atom (). Continuous shape measurements performed by SHAPE program reveal that both of them exhibit a similar distortion with regard to ideal tetrahedra (ST of 0.88 and 0.39 for Zn1 and Zn2, respectively). Two of the three 4-NO2-pyz ligands (A and B) act as \u03bc-\u03baN1:\u03baN2 bridges between Zn1 and Zn2 atoms and arrange them into dimeric [Zn2(\u03bc-4-NO2-pz)2] cores in which a Zn\u22c5\u22c5\u22c5Zn distance of 3.68 \u00c5 is imposed. Hereafter, \u03bc-hydroxide and \u03bc-4-NO2-pz ligands (C molecules) emerge symmetrically from both zinc(II) atoms in an almost perpendicular arrangement to previous 4-NO2-pz linkers, thus joining adjacent dimeric cores into a one-dimensional double chain ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Double 1D chains of compound <bold>2</bold> showing coordination\nenvironments of Zn1 and Zn2 and \u03c0\u2013\u03c0 interactions\namong 4-NO<sub>2</sub>-pz ligands (double dashed orange lines). Color\ncoding: C = gray, H = pink, N = blue, O = red, M = green.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2017-01443m_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Double 1D chains of compound 2 showing coordination environments of Zn1 and Zn2 and \u03c0-\u03c0 interactions among 4-NO2-pz ligands (double dashed orange lines). Color coding: C = gray, H = pink, N = blue, O = red, M = green.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 30, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>2</bold>\n<xref ref-type=\"table-fn\" rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.013(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>1.987(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1B</oasis:entry>\n<oasis:entry>1.991(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1C</oasis:entry>\n<oasis:entry>1.986(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2C(i)</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1</oasis:entry>\n<oasis:entry>1.927(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O1(ii)</oasis:entry>\n<oasis:entry>1.992(2)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic>, \u2212<italic>y</italic>, \u2212<italic>z</italic>; (ii) \u2212<italic>x</italic> \u2013 1, \u2212<italic>y</italic>, \u2212<italic>z</italic>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 31, "type": "text", "classification": ["else"], "content": "<p>Given the alternative\nbridges along the chain (\u03bc-hydroxide\nand \u03bc-4-NO<sub>2</sub>-pz), which impose slightly different\nZn\u00b7\u00b7\u00b7Zn distances (3.45 and 3.84 \u00c5, respectively),\nA and B 4-NO<sub>2</sub>-pz molecules do not arise completely coplanar\nto each other, but an angle of 3.45\u00b0 is found between their aromatic\nrings. Nonetheless, this fact still permits establishing strong face-to-face\nintramolecular \u03c0\u2013\u03c0 interactions among consecutive\nA and B 4-NO<sub>2</sub>-pz ligands along the chain, which is propagated\nalong the crystallographic [1 0 0] direction.</p>", "clean_text": "Given the alternative bridges along the chain (\u03bc-hydroxide and \u03bc-4-NO2-pz), which impose slightly different Zn\u22c5\u22c5\u22c5Zn distances (3.45 and 3.84 \u00c5, respectively), A and B 4-NO2-pz molecules do not arise completely coplanar to each other, but an angle of 3.45\u00b0 is found between their aromatic rings. Nonetheless, this fact still permits establishing strong face-to-face intramolecular \u03c0-\u03c0 interactions among consecutive A and B 4-NO2-pz ligands along the chain, which is propagated along the crystallographic [1 0 0] direction.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 32, "type": "text", "classification": ["else"], "content": "<p>Lattice water\nmolecules are anchored to the chains by acting as\nhydrogen bonding receptors of bridging hydroxide anions (), while they also\nserve as a junction point among neighboring chains. In particular,\neach of O1w molecules brings two additional chains together by establishing\nhydrogen bonds with free \u2013 NO<sub>2</sub> groups, in such a\nway that the reference chain is surrounded by other six chains. In\nthe overall packing, double chains are arranged with two relative\ndispositions with regard to the mean plane containing metal centers\nand C ligand in order to maximize the supramolecular interactions\nand afford cohesiveness to the crystal building. In this sense, it\nis worth mentioning that oxygen atoms pertaining to nitro groups of\nadjacent chains are forced to be placed at distances within the range\nof hydrogen bonding interactions, though it should be considered as\na mere consequence of packing requirements.</p>", "clean_text": "Lattice water molecules are anchored to the chains by acting as hydrogen bonding receptors of bridging hydroxide anions (), while they also serve as a junction point among neighboring chains. In particular, each of O1w molecules brings two additional chains together by establishing hydrogen bonds with free - NO2 groups, in such a way that the reference chain is surrounded by other six chains. In the overall packing, double chains are arranged with two relative dispositions with regard to the mean plane containing metal centers and C ligand in order to maximize the supramolecular interactions and afford cohesiveness to the crystal building. In this sense, it is worth mentioning that oxygen atoms pertaining to nitro groups of adjacent chains are forced to be placed at distances within the range of hydrogen bonding interactions, though it should be considered as a mere consequence of packing requirements.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 33, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Packing of chains in <bold>2</bold> along crystallographic <italic>a</italic> axis. Hydrogen\nbonding scheme is detailed in the right\nside.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2017-01443m_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Packing of chains in 2 along crystallographic a axis. Hydrogen bonding scheme is detailed in the right side.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<title>Structural Description\nof {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>3</bold>)</title><p>Crystal structure\nof compound <bold>3</bold> builds up\nfrom single zigzag chains established from the junction of the aforementioned\ndimeric [Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>2</sub>]\ncores. Within these entities, crystallographically independent Zn1\nand Zn2 atoms maintain tetrahedral environments formed solely by pyrazolate\nnitrogen atoms, a fact that generates a large difference between both\nmetal centers (compared to those of compound <bold>2</bold>) in terms\nof distortion with regard to ideal polyhedron (ST = 0.25 and 1.31\nfor Zn1 and Zn2; ). This geometrical feature affects the relative disposition between\nA and B bridging 4-NO<sub>2</sub>-pz ligands (), which are slightly folded and acquire\nan angle of 24.8\u00b0 between their aromatic rings. Hereafter, two\nadditional centrosymmetric dimeric cores are emerged from each metal\ncenter owing to the coordination of C and D ligands, which act as\n\u03bc-\u03baN1:\u03baN2 bridges and bring the fusion of the dimers\ninto a 1D array.</p>", "clean_text": "Structural Description of {[Zn2(\u03bc-4-NO2-pz)4]} n  (3)\n\nCrystal structure of compound 3 builds up from single zigzag chains established from the junction of the aforementioned dimeric [Zn2(\u03bc-4-NO2-pz)2] cores. Within these entities, crystallographically independent Zn1 and Zn2 atoms maintain tetrahedral environments formed solely by pyrazolate nitrogen atoms, a fact that generates a large difference between both metal centers (compared to those of compound 2) in terms of distortion with regard to ideal polyhedron (ST = 0.25 and 1.31 for Zn1 and Zn2; ). This geometrical feature affects the relative disposition between A and B bridging 4-NO2-pz ligands (), which are slightly folded and acquire an angle of 24.8\u00b0 between their aromatic rings. Hereafter, two additional centrosymmetric dimeric cores are emerged from each metal center owing to the coordination of C and D ligands, which act as \u03bc-\u03baN1:\u03baN2 bridges and bring the fusion of the dimers into a 1D array.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>One-dimensional chain of <bold>3</bold> established from\nthe fusion\nof dimeric cores together with tetrahedral coordination environments.\nNumbering scheme for 4-NO<sub>2</sub>-pz ligands is shown.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"cg-2017-01443m_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  One-dimensional chain of 3 established from the fusion of dimeric cores together with tetrahedral coordination environments. Numbering scheme for 4-NO2-pz ligands is shown.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 36, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>3</bold>\n<xref ref-type=\"table-fn\" rid=\"t3fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.010(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N1D</oasis:entry>\n<oasis:entry>1.987(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1B</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>1.986(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1C</oasis:entry>\n<oasis:entry>2.000(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N2C(i)</oasis:entry>\n<oasis:entry>2.009(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2D(ii)</oasis:entry>\n<oasis:entry>1.999(2)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t3fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic> + 2, \u2212<italic>y</italic> + 1, \u2212<italic>z</italic> + 1; (ii) \u2212<italic>x</italic> + 2, \u2212<italic>y</italic>, \u2212<italic>z</italic> + 2.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 37, "type": "text", "classification": ["else"], "content": "<p>As a consequence,\nconsecutive 4-NO<sub>2</sub>-pz ligands are arranged\nalmost perpendicular to each other, minimizing the sterical hindrance,\nwhile the corrugated chain is extended [Zn1\u00b7\u00b7\u00b7Zn2\u00b7\u00b7\u00b7Zn2\u00ad(ii)\nof 144.6\u00b0] along the [01\u03051] direction.</p>", "clean_text": "As a consequence, consecutive 4-NO2-pz ligands are arranged almost perpendicular to each other, minimizing the sterical hindrance, while the corrugated chain is extended [Zn1\u22c5\u22c5\u22c5Zn2\u22c5\u22c5\u22c5Zn2(ii) of 144.6\u00b0] along the [01\u03051] direction.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 38, "type": "text", "classification": "error", "content": "<p>Despite of\nthe aromatic nature of 4-NO<sub>2</sub>-pz ligands,\nonly very weak intramolecular edge-to-face \u03c0\u2013\u03c0\ninteractions are allowed to happen along the chains given their relative\narrangement (see <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">Table S3</ext-link>). Instead, much\nmore efficient \u03c0\u2013\u03c0 interactions are established\nbetween B ligands belonging to neighboring chains arranged face-to-face\none another, leading to layers spreading along the <italic>bc</italic> plane ().\nThese interactions are in turn reinforced by weaker R<sup>2</sup>\n<sub>2</sub>(10) hydrogen bonding rings formed by C\u2013H\u00b7\u00b7\u00b7O<sub>nitro</sub> bonds between almost parallel rings. These symmetric interactions, although of weaker nature,\nresemble base-pairings found in nucleobase based complexes, such as\nrecurrent patterns established between Hoogsteen sides of two adenine\nmolecules or Asn/Glu\u2013adenine interaction in protein\u2013nucleic\nacid complexes. Pilling of the layers of 1D chains\nalong crystallographic <italic>a</italic> axis takes place due to\nthe occurrence of additional supramolecular interactions, among which\nC\u2013H\u00b7\u00b7\u00b7O<sub>nitro</sub> (with somewhat acute\nangles) as well as perpendicular O<sub>nitro</sub>\u00b7\u00b7\u00b7ring-pz\ncontacts. Further analysis of the crystal structure by means of Platon\nsoftware reveals the presence of very\nsmall voids in which even a water molecule does not enter (28.4 \u00c5<sup>3</sup> per unit cell volume, 2.9%). Therefore, at first sight, one\nmay anticipate the lack of strong cohesion in the overall crystal\nbuilding of <bold>3</bold>.</p>", "clean_text": "Despite of the aromatic nature of 4-NO2-pz ligands, only very weak intramolecular edge-to-face \u03c0-\u03c0 interactions are allowed to happen along the chains given their relative arrangement (see Table S3). Instead, much more efficient \u03c0-\u03c0 interactions are established between B ligands belonging to neighboring chains arranged face-to-face one another, leading to layers spreading along the bc plane (). These interactions are in turn reinforced by weaker R2 2(10) hydrogen bonding rings formed by C-H\u22c5\u22c5\u22c5Onitro bonds between almost parallel rings. These symmetric interactions, although of weaker nature, resemble base-pairings found in nucleobase based complexes, such as recurrent patterns established between Hoogsteen sides of two adenine molecules or Asn/Glu-adenine interaction in protein-nucleic acid complexes. Pilling of the layers of 1D chains along crystallographic a axis takes place due to the occurrence of additional supramolecular interactions, among which C-H\u22c5\u22c5\u22c5Onitro (with somewhat acute angles) as well as perpendicular Onitro\u22c5\u22c5\u22c5ring-pz contacts. Further analysis of the crystal structure by means of Platon software reveals the presence of very small voids in which even a water molecule does not enter (28.4 \u00c53 per unit cell volume, 2.9%). Therefore, at first sight, one may anticipate the lack of strong cohesion in the overall crystal building of 3.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Crystal building of compound <bold>3</bold> detailing\na summary\nof supramolecular interactions among 1D chains.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"cg-2017-01443m_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Crystal building of compound 3 detailing a summary of supramolecular interactions among 1D chains.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 40, "type": "text", "classification": "error", "content": "<title>Structural Description of {[Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>(\u03bc-ac)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>4</bold>)</title><p>X-ray diffraction analysis of compound <bold>4</bold> reveals a similar\nstructural nature of compound <bold>3</bold> since it also consists\nof polymeric chains. In fact, chains composing compound <bold>4</bold> may be considered as the result of the replacement of some 4-NO<sub>2</sub>-pz bridges by acetate linkers. Two independent zinc\u00ad(II) atoms\nare distinguished in the asymmetric unit. Zn1 atom lies on an inversion\ncenter and exhibits an almost ideal octahedral environment (SOC =\n0.22), whereas Zn2 displays a less common pentacoordinated donor set\nformed by three nitrogen pyrazolate atoms and two chelating carboxylate\noxygen atoms, which may be defined as a severely distorted trigonal\nbipyramid (STBPY = 2.44) (). The presence of such different environments may\nbe attributed to the \u03bc-ac ligand, which alternatively replaces\na \u03bc-4-NO<sub>2</sub>-pz bridge along the chain (). Moreover, it is able to\npreserve the corrugated chain motif described for compound <bold>3</bold> by acquiring the \u03bc-\u03ba<sub>2</sub>O11,O12:\u03baO12 bridging\nmode in order to accommodate the Zn\u00b7\u00b7\u00b7Zn imposed by\nthe 4-NO<sub>2</sub>-pz bridge. In this sense, the smaller steric\nhindrance imposed by acetate ligand favors the incorporation of two\nwater molecules in the coordination shell of Zn1 so that it gains\nstability with regard to the initial coordination of acetate and pyrazolate\nmoieties at the vertices of a square plane. Therefore, two different\nbuilding units are to be distinguished: centrosymmetric [Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>2</sub>] cores and mixed [Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)\u00ad(\u03bc-ac)] dimers, both of\nwhich are joined into corrugated chains running along the <italic>c</italic> axis. However, a subtle difference is worth highlighting,\npaying attention to the way in which these units are assembled since,\nin this case, the alternative propagation of both dimeric cores involves\na Zn2\u00ad(i)\u00b7\u00b7\u00b7Zn1\u00b7\u00b7\u00b7Zn2\u00b7\u00b7\u00b7Zn2\u00ad(ii)\nsequence instead of previously observed Zn1\u00ad(i)\u00b7\u00b7\u00b7Zn1\u00b7\u00b7\u00b7Zn2\u00b7\u00b7\u00b7Zn2\u00ad(ii)\none.</p>", "clean_text": "Structural Description of {[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n  (4)\n\nX-ray diffraction analysis of compound 4 reveals a similar structural nature of compound 3 since it also consists of polymeric chains. In fact, chains composing compound 4 may be considered as the result of the replacement of some 4-NO2-pz bridges by acetate linkers. Two independent zinc(II) atoms are distinguished in the asymmetric unit. Zn1 atom lies on an inversion center and exhibits an almost ideal octahedral environment (SOC = 0.22), whereas Zn2 displays a less common pentacoordinated donor set formed by three nitrogen pyrazolate atoms and two chelating carboxylate oxygen atoms, which may be defined as a severely distorted trigonal bipyramid (STBPY = 2.44) (). The presence of such different environments may be attributed to the \u03bc-ac ligand, which alternatively replaces a \u03bc-4-NO2-pz bridge along the chain (). Moreover, it is able to preserve the corrugated chain motif described for compound 3 by acquiring the \u03bc-\u03ba2O11,O12:\u03baO12 bridging mode in order to accommodate the Zn\u22c5\u22c5\u22c5Zn imposed by the 4-NO2-pz bridge. In this sense, the smaller steric hindrance imposed by acetate ligand favors the incorporation of two water molecules in the coordination shell of Zn1 so that it gains stability with regard to the initial coordination of acetate and pyrazolate moieties at the vertices of a square plane. Therefore, two different building units are to be distinguished: centrosymmetric [Zn2(\u03bc-4-NO2-pz)2] cores and mixed [Zn2(\u03bc-4-NO2-pz)(\u03bc-ac)] dimers, both of which are joined into corrugated chains running along the c axis. However, a subtle difference is worth highlighting, paying attention to the way in which these units are assembled since, in this case, the alternative propagation of both dimeric cores involves a Zn2(i)\u22c5\u22c5\u22c5Zn1\u22c5\u22c5\u22c5Zn2\u22c5\u22c5\u22c5Zn2(ii) sequence instead of previously observed Zn1(i)\u22c5\u22c5\u22c5Zn1\u22c5\u22c5\u22c5Zn2\u22c5\u22c5\u22c5Zn2(ii) one.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 41, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Coordination environments of Zn1 and Zn2 atoms together with the\ncorrugated chain of compound <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"cg-2017-01443m_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Coordination environments of Zn1 and Zn2 atoms together with the corrugated chain of compound 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 42, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl4\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>4</bold>\n<xref ref-type=\"table-fn\" rid=\"t4fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.023(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A(i)</oasis:entry>\n<oasis:entry>2.023(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N1B</oasis:entry>\n<oasis:entry>2.010(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O11C</oasis:entry>\n<oasis:entry>2.151(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B(ii)</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O11C(i)</oasis:entry>\n<oasis:entry>2.151(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O11C(i)</oasis:entry>\n<oasis:entry>2.295(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1w</oasis:entry>\n<oasis:entry>2.242(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O12C(i)</oasis:entry>\n<oasis:entry>2.063(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1w(i)</oasis:entry>\n<oasis:entry>2.242(2)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t4fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic> + 1/2, \u2212<italic>y</italic> + 1/2, \u2212<italic>z</italic> + 1; (ii) \u2212<italic>x</italic> + 1/2, \u2212<italic>y</italic> + 1/2, \u2212<italic>z</italic>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 43, "type": "text", "classification": ["else"], "content": "<p>Packing of\nthe chains is driven by the same kind of forces following\na similar scheme to that previously observed for compound <bold>3</bold>. First, strong face-to-face chains \u03c0\u2013\u03c0 (between\nA and B 4-NO<sub>2</sub>-pz ligands) as well as hydrogen bonding interactions\n(involving coordination water molecules and O<sub>nitro</sub> groups)\nare established among moieties belonging to two adjacent chains, which\ngenerates well united layers spreading along <italic>ac</italic> plane\n(see  and <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">Supporting Information</ext-link>).</p>", "clean_text": "Packing of the chains is driven by the same kind of forces following a similar scheme to that previously observed for compound 3. First, strong face-to-face chains \u03c0-\u03c0 (between A and B 4-NO2-pz ligands) as well as hydrogen bonding interactions (involving coordination water molecules and Onitro groups) are established among moieties belonging to two adjacent chains, which generates well united layers spreading along ac plane (see  and Supporting Information).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 44, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Packing of compound <bold>4</bold> showing supramolecular interactions\noccurring among corrugated chains.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"cg-2017-01443m_0007.tif\"></graphic>\n</fig>", "clean_text": " 7  Packing of compound 4 showing supramolecular interactions occurring among corrugated chains.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 45, "type": "text", "classification": ["else"], "content": "<p>Then, these layers are piled along the crystallographic <italic>c</italic> axis in a staggered fashion owing to additional hydrogen\nand \u03c0\u2013\u03c0 bonds occurring between intercrossing chains\nin such a way that each chain interacts with four neighboring ones.\nAll these interactions give rise to the 3D compact architecture of <bold>4</bold>.</p>", "clean_text": "Then, these layers are piled along the crystallographic c axis in a staggered fashion owing to additional hydrogen and \u03c0-\u03c0 bonds occurring between intercrossing chains in such a way that each chain interacts with four neighboring ones. All these interactions give rise to the 3D compact architecture of 4.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 46, "type": "text", "classification": ["else"], "content": "<title>Solution NMR Studies</title><p>Apart from\nthe crystallographic\ncharacterization and elemental analysis, except for compound <bold>2</bold>, standard analytical methods such as NMR and MS spectrometry\nwere used to verify the characterization of the metal complexes in\nsolution to corroborate that species <bold>3</bold> and <bold>4</bold> are present in the biological assays. In particular, MS (ESI) spectrometry\nfrom polar solvents such as dimethyl sulfoxide gave evidence for the\nretention of the ligands and polymetallic scaffold in solution. In\nthe coordination polymer <bold>3</bold>, the negative ion mode revealed\na parent ion corresponding to [Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>(HO)]<sup>\u2212</sup> with <italic>m</italic>/<italic>z</italic> of 591.81854, which only differs from the solid state\nin the incorporation of one hydroxide molecule. As expected, the observed\nisotope pattern matches well with the one calculated for the exact\nmass of C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>9</sub>Zn<sub>2</sub> (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">Figure S14</ext-link>).</p>", "clean_text": "Solution NMR Studies\n\nApart from the crystallographic characterization and elemental analysis, except for compound 2, standard analytical methods such as NMR and MS spectrometry were used to verify the characterization of the metal complexes in solution to corroborate that species 3 and 4 are present in the biological assays. In particular, MS (ESI) spectrometry from polar solvents such as dimethyl sulfoxide gave evidence for the retention of the ligands and polymetallic scaffold in solution. In the coordination polymer 3, the negative ion mode revealed a parent ion corresponding to [Zn2(\u03bc-4-NO2-pz)4(HO)]- with m/z of 591.81854, which only differs from the solid state in the incorporation of one hydroxide molecule. As expected, the observed isotope pattern matches well with the one calculated for the exact mass of C12H8N12O9Zn2 (Figure S14).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 47, "type": "text", "classification": ["else"], "content": "<p>In complex <bold>4</bold>, however, the molecular ion is [Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>3</sub>(\u03bc-ac)\u00ad(H<sub>2</sub>O)<sub>2</sub>]<sup>\u2212</sup> with <italic>m</italic>/<italic>z</italic> of 622.91715,\nwhich corresponds to an ion that has kept their three zinc metals,\nbut misses a pyrazolyl and an acetate ligand. These results evidenced\nthat the trinuclear scaffold is strong enough to persist in the gas\nphase, but the ligand lability slightly differs from one complex to\nanother. The latter statement is supported by other fragments observed\nin the mass spectrum that derived from the substitution of some pyrazolyl\nligands by dimethyl sulfoxide, the solvent of choice. Parent ions\nsuch as [Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)\u00ad(DMSO)<sub>2</sub>(\u03bc-ac)\u00ad(H<sub>2</sub>O)<sub>2</sub>]<sup>\u2212</sup> and\n[Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)\u00ad(DMSO)<sub>2</sub>(\u03bc-ac)]<sup>\u2212</sup> at 553.90308 and 516.91333, respectively, were also\nobserved. Accordingly, their experimental isotope patterns match well\nwith those calculated for C<sub>9</sub>H<sub>21</sub>N<sub>3</sub>O<sub>8</sub>S<sub>2</sub>Zn<sub>3</sub> and C<sub>9</sub>H<sub>16</sub>N<sub>3</sub>O<sub>6</sub>S<sub>2</sub>Zn<sub>3</sub>, respectively\n(<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">Figures S16 and 17</ext-link>).</p>", "clean_text": "In complex 4, however, the molecular ion is [Zn3(\u03bc-4-NO2-pz)3(\u03bc-ac)(H2O)2]- with m/z of 622.91715, which corresponds to an ion that has kept their three zinc metals, but misses a pyrazolyl and an acetate ligand. These results evidenced that the trinuclear scaffold is strong enough to persist in the gas phase, but the ligand lability slightly differs from one complex to another. The latter statement is supported by other fragments observed in the mass spectrum that derived from the substitution of some pyrazolyl ligands by dimethyl sulfoxide, the solvent of choice. Parent ions such as [Zn3(\u03bc-4-NO2-pz)(DMSO)2(\u03bc-ac)(H2O)2]- and [Zn3(\u03bc-4-NO2-pz)(DMSO)2(\u03bc-ac)]- at 553.90308 and 516.91333, respectively, were also observed. Accordingly, their experimental isotope patterns match well with those calculated for C9H21N3O8S2Zn3 and C9H16N3O6S2Zn3, respectively (Figures S16 and 17).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 48, "type": "text", "classification": ["else"], "content": "<p>The one-dimensional\n(1D) and two-dimensional (2D) NMR spectra of\ncomplexes <bold>3</bold> and <bold>4</bold> were recorded in anhydrous\ndeuterated dimethyl sulfoxide and are presented in the <ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">Supporting Information</ext-link> (Figures S1\u2013S12).\nThe resonances found for both complexes are consistent with metalated\npyrazole structures such as those obtained in the solid state.</p>", "clean_text": "The one-dimensional (1D) and two-dimensional (2D) NMR spectra of complexes 3 and 4 were recorded in anhydrous deuterated dimethyl sulfoxide and are presented in the Supporting Information (Figures S1-S12). The resonances found for both complexes are consistent with metalated pyrazole structures such as those obtained in the solid state.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 49, "type": "text", "classification": "error", "content": "<p>The room temperature <sup>1</sup>H NMR spectrum for the coordination\npolymer <bold>3</bold> displays two broad singlets of different intensity\nfor the 3,5-CHpz protons at \u03b4<sub>H</sub> 8.31 and 8.53 ppm.\nThe broadened proton resonances obtained indicated a fluxional behavior\nbetween the magnetically different pyrazolyl ligands. We therefore\nperformed high-temperature NMR measurements in order to increase the\nexchange rate of the fluxional process and get sharper signals. To\nour delight, upon heating a [<italic>d</italic>\n<sub>6</sub>]-DMSO\nsolution of <bold>3</bold>, we could observe how the signal sharpens\nat 323 K (<italic>W</italic>\n<sub>1/2</sub> = 14.9 Hz), what proved\nthe latter statement. In the <sup>13</sup>C NMR spectrum, two signals\nwere observed at \u03b4<sub>C</sub> 135.1 and 137.1 ppm, for the\nquaternary and methine carbons, respectively, what again matches with\nan average situation in solution, where all the pyrazolyl units are\nin fast exchange at this temperature.</p>", "clean_text": "The room temperature 1H NMR spectrum for the coordination polymer 3 displays two broad singlets of different intensity for the 3,5-CHpz protons at \u03b4H 8.31 and 8.53 ppm. The broadened proton resonances obtained indicated a fluxional behavior between the magnetically different pyrazolyl ligands. We therefore performed high-temperature NMR measurements in order to increase the exchange rate of the fluxional process and get sharper signals. To our delight, upon heating a [d 6]-DMSO solution of 3, we could observe how the signal sharpens at 323 K (W 1/2 = 14.9 Hz), what proved the latter statement. In the 13C NMR spectrum, two signals were observed at \u03b4C 135.1 and 137.1 ppm, for the quaternary and methine carbons, respectively, what again matches with an average situation in solution, where all the pyrazolyl units are in fast exchange at this temperature.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 50, "type": "text", "classification": "error", "content": "<p>Complex <bold>4</bold> shows in the <sup>1</sup>H NMR spectrum\ntwo sharp signals located at \u03b4<sub>H</sub> 8.25 and 1.98 ppm\nassigned to 3,5-CHpz and acetate protons, respectively. Interestingly,\nthe ratio between both signals is 4 to 3, what confirms the stoichiometry\nfound in the solid state. At room temperature the exchange rate between\npyrazolyl ligands is fast as it is deduced from the sharp signals\nobserved in the spectrum. Again, the chemical shift of the pyrazole\nprotons fit well with metalated ligands as observed in complex <bold>3</bold>. The <sup>13</sup>C NMR spectrum shows three resonances\nat \u03b4<sub>C</sub> 178.6, 136.8, 135.3, and 22.9, assigned to\nthe carbonyl (acetate), methine (pyrazole), quaternary (pyrazole),\nand methyl (acetate) carbons, respectively.</p>", "clean_text": "Complex 4 shows in the 1H NMR spectrum two sharp signals located at \u03b4H 8.25 and 1.98 ppm assigned to 3,5-CHpz and acetate protons, respectively. Interestingly, the ratio between both signals is 4 to 3, what confirms the stoichiometry found in the solid state. At room temperature the exchange rate between pyrazolyl ligands is fast as it is deduced from the sharp signals observed in the spectrum. Again, the chemical shift of the pyrazole protons fit well with metalated ligands as observed in complex 3. The 13C NMR spectrum shows three resonances at \u03b4C 178.6, 136.8, 135.3, and 22.9, assigned to the carbonyl (acetate), methine (pyrazole), quaternary (pyrazole), and methyl (acetate) carbons, respectively.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 51, "type": "text", "classification": "error", "content": "<title>Potential Antiproliferative\nActivities</title><p>We assayed the\nproliferation effect of the ligand (Nitro-1<italic>H</italic>-pyrazole)\nand two Zn-MOCs (compounds <bold>3</bold> and <bold>4</bold>) on three\ndifferent cell lines, B16-F10 murine melanoma cells, HT29 colon cancer\ncells, and HepG2 hepatome cells. Cell viability was tested in these\nthree different cell lines by MTS assay at increased concentrations\nof compounds <bold>1</bold>, <bold>3</bold>, and <bold>4</bold> (range\nfrom 0 to 100 \u03bcg/mL). The viabilities () were determined by formazan dye uptake\nand expressed as percentage with respect to untreated control cells.\nIC<sub>50</sub>, which means product concentration required to inhibit\ncell growth at 50%, was determined for each compound on these three\ncell lines (). Also, we determinate the product concentration required for 20%\nand 80% growth inhibition (IC<sub>20</sub> and IC<sub>80</sub>) to\nanalyze the complete range of cytotoxicity.</p>", "clean_text": "Potential Antiproliferative Activities\n\nWe assayed the proliferation effect of the ligand (Nitro-1H-pyrazole) and two Zn-MOCs (compounds 3 and 4) on three different cell lines, B16-F10 murine melanoma cells, HT29 colon cancer cells, and HepG2 hepatome cells. Cell viability was tested in these three different cell lines by MTS assay at increased concentrations of compounds 1, 3, and 4 (range from 0 to 100 \u03bcg/mL). The viabilities () were determined by formazan dye uptake and expressed as percentage with respect to untreated control cells. IC50, which means product concentration required to inhibit cell growth at 50%, was determined for each compound on these three cell lines (). Also, we determinate the product concentration required for 20% and 80% growth inhibition (IC20 and IC80) to analyze the complete range of cytotoxicity.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 52, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>Effects of compounds <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>, on the viability of\nB16-F10, HT29, and HepG2 cancer cells,\nafter treatment with the compounds for 72 h in a range of 0 to 100\n\u03bcg/mL, each point represents the mean value \u00b1 SD of at\nleast two independent experiments performed in triplicate.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"cg-2017-01443m_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  Effects of compounds 1, 3, and 4, on the viability of B16-F10, HT29, and HepG2 cancer cells, after treatment with the compounds for 72 h in a range of 0 to 100 \u03bcg/mL, each point represents the mean value \u00b1 SD of at least two independent experiments performed in triplicate.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 53, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl5\" position=\"float\">\n<label>5</label>\n<caption>\n<title>Growth-Inhibitory Effects of Compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> on the\nThree Cancer Cell Lines</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"8\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col7\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col8\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">cell line</oasis:entry>\n<oasis:entry align=\"center\">compd\u00a0#</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>20</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/IC of compound</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>50</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/ IC of compound</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>80</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/IC of compound</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>HT29</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>56.5\u00a0\u00b1\u00a08.0</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>97.6\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>216.5\u00a0\u00b1\u00a016.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>23.2\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>46.7\u00a0\u00b1\u00a08.8</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>77.3\u00a0\u00b1\u00a013.7</oasis:entry>\n<oasis:entry>2.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>18.8\u00a0\u00b1\u00a09.3</oasis:entry>\n<oasis:entry>3.0</oasis:entry>\n<oasis:entry>41.8\u00a0\u00b1\u00a015.0</oasis:entry>\n<oasis:entry>2.3</oasis:entry>\n<oasis:entry>75.2\u00a0\u00b1\u00a015.8</oasis:entry>\n<oasis:entry>2.9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Hep-G2</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>50.9\u00a0\u00b1\u00a016.4</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>210.6\u00a0\u00b1\u00a016.1</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>521.0\u00a0\u00b1\u00a015.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>17.4\u00a0\u00b1\u00a03.9</oasis:entry>\n<oasis:entry>2.9</oasis:entry>\n<oasis:entry>45.4\u00a0\u00b1\u00a01.9</oasis:entry>\n<oasis:entry>4.6</oasis:entry>\n<oasis:entry>78.0\u00a0\u00b1\u00a00.2</oasis:entry>\n<oasis:entry>6.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>15.1\u00a0\u00b1\u00a02.6</oasis:entry>\n<oasis:entry>3.4</oasis:entry>\n<oasis:entry>45.8\u00a0\u00b1\u00a02.7</oasis:entry>\n<oasis:entry>4.6</oasis:entry>\n<oasis:entry>80.5\u00a0\u00b1\u00a01.6</oasis:entry>\n<oasis:entry>6.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>B16-F10</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>82.7\u00a0\u00b1\u00a011.5</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>101.8\u00a0\u00b1\u00a01.1</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>113.6\u00a0\u00b1\u00a06.3</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>33.9\u00a0\u00b1\u00a06.3</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>52.6\u00a0\u00b1\u00a01.4</oasis:entry>\n<oasis:entry>1.9</oasis:entry>\n<oasis:entry>73.4\u00a0\u00b1\u00a02.4</oasis:entry>\n<oasis:entry>1.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>15.9\u00a0\u00b1\u00a06.9</oasis:entry>\n<oasis:entry>5.2</oasis:entry>\n<oasis:entry>47.8\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>78.3\u00a0\u00b1\u00a04.1</oasis:entry>\n<oasis:entry>1.5</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 54, "type": "text", "classification": ["property"], "content": "<p>Both\ncoordination complexes (compounds <bold>3</bold> and <bold>4</bold>) show cytotoxicity properties at the conditions assayed\n(0 to 100 \u03bcg/mL) with IC<sub>50</sub> data range between 42\nto 53 \u03bcg/mL, IC<sub>20</sub> data between 15 to 34 \u03bcg/mL,\nand IC<sub>80</sub> data between 73 to 80 \u03bcg/mL.</p>", "clean_text": "Both coordination complexes (compounds 3 and 4) show cytotoxicity properties at the conditions assayed (0 to 100 \u03bcg/mL) with IC50 data range between 42 to 53 \u03bcg/mL, IC20 data between 15 to 34 \u03bcg/mL, and IC80 data between 73 to 80 \u03bcg/mL.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 55, "type": "text", "classification": "error", "content": "<p>The effectiveness\nshowed for these coordination complexes was different\nin each cell line assayed; however, in all cases we have an improvement\nin the compounds cytotoxicity\u2019s results compared to the ligand\nvalues; at IC<sub>50</sub> concentrations, the lowest values was obtained\nin B16-F10 cell line (53%), and the highest one on HT29 (62%) and\nHep G2 cells (81%). As conclusion, the IC<sub>50</sub> cytotoxicity\nvalues are lower in Hep-G2 hepatome cells and HT29 colon cancer cells\nthan in B16-F10 melanoma cells.</p>", "clean_text": "The effectiveness showed for these coordination complexes was different in each cell line assayed; however, in all cases we have an improvement in the compounds cytotoxicity's results compared to the ligand values; at IC50 concentrations, the lowest values was obtained in B16-F10 cell line (53%), and the highest one on HT29 (62%) and Hep G2 cells (81%). As conclusion, the IC50 cytotoxicity values are lower in Hep-G2 hepatome cells and HT29 colon cancer cells than in B16-F10 melanoma cells.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 56, "type": "text", "classification": "error", "content": "<p>The most effective compound\nwas the compound <bold>4</bold>, although\nwith no significant differences from the other Zn complex. In all\ncell lines assayed, compound <bold>4</bold> show cytotoxic effects\nat lower concentrations than compound <bold>3</bold>, especially in\nHT29 and B16-F10 cell lines (see IC<sub>20</sub> values, ). In Hep-G2 cell\nline, the onset of the cytotoxic effect occurs in a similar way to\nboth compounds, with concentrations close to 16 \u03bcg/mL. For all\ncomplexes and in all cell lines assayed, the highest cytotoxic effect\nis reached at similar concentrations, around 75 \u03bcg/mL (see IC<sub>80</sub> values, ).</p>", "clean_text": "The most effective compound was the compound 4, although with no significant differences from the other Zn complex. In all cell lines assayed, compound 4 show cytotoxic effects at lower concentrations than compound 3, especially in HT29 and B16-F10 cell lines (see IC20 values, ). In Hep-G2 cell line, the onset of the cytotoxic effect occurs in a similar way to both compounds, with concentrations close to 16 \u03bcg/mL. For all complexes and in all cell lines assayed, the highest cytotoxic effect is reached at similar concentrations, around 75 \u03bcg/mL (see IC80 values, ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 57, "type": "text", "classification": ["else"], "content": "<p>In general terms, we found that complexes showed lower IC<sub>50</sub> than 4-NO<sub>2</sub>-pz ligand. This ligand displayed a\nlow cytotoxicity\nin all cells lines assayed, and these cytotoxicities were increased\nwith the formation of coordination complex.</p>", "clean_text": "In general terms, we found that complexes showed lower IC50 than 4-NO2-pz ligand. This ligand displayed a low cytotoxicity in all cells lines assayed, and these cytotoxicities were increased with the formation of coordination complex.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 58, "type": "text", "classification": ["else"], "content": "<p>Currently, many\nanticancer drugs dosages are limited by side effects,\nwhich prevent the complete treatment of cancer in patients. For example,\ncisplatin is the most widely used chemotherapeutic drug for treatment\nin different cancer types. However, cisplatin produces many side effects,\nsuch as nephrotoxicity. Other coordination\ncomplexes do not exhibit adequate stability for <italic>in vivo</italic> applications. Our results showed the low cytotoxicity of the pyridazole\nby itself, which enhances with the formation of coordination polymers.</p>", "clean_text": "Currently, many anticancer drugs dosages are limited by side effects, which prevent the complete treatment of cancer in patients. For example, cisplatin is the most widely used chemotherapeutic drug for treatment in different cancer types. However, cisplatin produces many side effects, such as nephrotoxicity. Other coordination complexes do not exhibit adequate stability for in vivo applications. Our results showed the low cytotoxicity of the pyridazole by itself, which enhances with the formation of coordination polymers.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 59, "type": "text", "classification": ["else"], "content": "<p>These results showed that the cytotoxic effect of Zn complexes\non HT29 colon cancer cells, Hep-G2 hepatome cells, and B16-F10 melanome\ncells present few variations with respect to cell type. There were\nalso no significant differences among cytotoxicity influence of the\ncomplexes examined, which indicates that different substituent on\nthe ligands did not have a clear influence.</p>", "clean_text": "These results showed that the cytotoxic effect of Zn complexes on HT29 colon cancer cells, Hep-G2 hepatome cells, and B16-F10 melanome cells present few variations with respect to cell type. There were also no significant differences among cytotoxicity influence of the complexes examined, which indicates that different substituent on the ligands did not have a clear influence.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 60, "type": "text", "classification": "error", "content": "<p>Colon cancer cells\nseemed to be more sensitive to both Zn-pyridazole\ncomplexes; also, this cell line showed lower IC<sub>50</sub> value\nin the pyridazole treatment (). The higher difference between coordination complexes\ntreatment with respect to pyridazole treatment were found in the Hep-G2\ncells, being approximately 5-fold more cytotoxic than the pyridazole\nligand. Thus, these synthesized Zn-MOCs show significant advantages\nover the existing system. These materials avoid the potential self-aggregation\nissue often encountered by other anticancer compound such as triterpenes and minimize nonspecific interactions suggesting that these compounds\ncan be considered effective drugs for potential treatment from cancer.</p>", "clean_text": "Colon cancer cells seemed to be more sensitive to both Zn-pyridazole complexes; also, this cell line showed lower IC50 value in the pyridazole treatment (). The higher difference between coordination complexes treatment with respect to pyridazole treatment were found in the Hep-G2 cells, being approximately 5-fold more cytotoxic than the pyridazole ligand. Thus, these synthesized Zn-MOCs show significant advantages over the existing system. These materials avoid the potential self-aggregation issue often encountered by other anticancer compound such as triterpenes and minimize nonspecific interactions suggesting that these compounds can be considered effective drugs for potential treatment from cancer.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 61, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Growth-inhibitory\neffects (IC<sub>20</sub>, IC<sub>50</sub>, and\nIC<sub>80</sub>, \u03bcg/mL) of compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> on the three cancer cell lines.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"cg-2017-01443m_0009.tif\"></graphic>\n</fig>", "clean_text": " 9  Growth-inhibitory effects (IC20, IC50, and IC80, \u03bcg/mL) of compounds 1, 2, 3, and 4 on the three cancer cell lines.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 62, "type": "text", "classification": ["else"], "content": "<title>Conclusions</title><p>In\nsummary, we have developed novel 1D Zn-coordination complexes\nwith interesting structural properties that show significant advantages\nover existing antitumor systems. The self-t-assembly of coordination\ncomplexes carried out under mild conditions, making complex highly\nstables. These compounds constitute the first examples of polymeric\nstructures based on 4-NO<sub>2</sub>-pyrazole ligands. Zn-coordination\ncomplex avoids the potential self-aggregation issue often encountered\nby other anticancer compounds such as triterpenes and minimize nonspecific\ninteractions. NMR and MS spectrometry verified the presence of metal\ncomplexes in solution to corroborate that these materials are present\nin the biological assays. These results suggest that Zn-MOCs represent\nimportant novel and effective drugs for potential treatment from cancer.\nFutures studies will be necessary to characterize completely its anticancer\neffects.</p>", "clean_text": "Conclusions\n\nIn summary, we have developed novel 1D Zn-coordination complexes with interesting structural properties that show significant advantages over existing antitumor systems. The self-t-assembly of coordination complexes carried out under mild conditions, making complex highly stables. These compounds constitute the first examples of polymeric structures based on 4-NO2-pyrazole ligands. Zn-coordination complex avoids the potential self-aggregation issue often encountered by other anticancer compounds such as triterpenes and minimize nonspecific interactions. NMR and MS spectrometry verified the presence of metal complexes in solution to corroborate that these materials are present in the biological assays. These results suggest that Zn-MOCs represent important novel and effective drugs for potential treatment from cancer. Futures studies will be necessary to characterize completely its anticancer effects.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 63, "type": "text", "classification": ["else"], "content": "<p>The Supporting Information\nis available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\">ACS Publications website</ext-link> at DOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acs.cgd.7b01443\">10.1021/acs.cgd.7b01443</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>Additional figures\nof crystallographic data and FT-IR,\nNMR, and high-resolution mass spectrometry (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n</list>\n</p>", "clean_text": "The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.cgd.7b01443.  Additional figures of crystallographic data and FT-IR, NMR, and high-resolution mass spectrometry (PDF)   ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 64, "type": "text", "classification": ["else"], "content": "<p>Additional figures\nof crystallographic data and FT-IR,\nNMR, and high-resolution mass spectrometry (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acs.cgd.7b01443/suppl_file/cg7b01443_si_001.pdf\">PDF</ext-link>)</p><p>CCDC <ext-link ext-link-type=\"ccdc\" xlink:href=\"1514766\">1514766</ext-link>\u2013<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514769\">1514769</ext-link> contain the supplementary crystallographic data\nfor this paper. These data can be obtained free of charge via <ext-link xlink:href=\"http://www.ccdc.cam.ac.uk/data_request/cif\">www.ccdc.cam.ac.uk/data_request/cif</ext-link>, or by emailing <email>data_request@ccdc.cam.ac.uk</email>, or by\ncontacting The Cambridge Crystallographic Data Centre, 12 Union Road,\nCambridge CB2 1EZ, UK; fax: +44 1223 336033.</p>", "clean_text": "Additional figures of crystallographic data and FT-IR, NMR, and high-resolution mass spectrometry (PDF)\n\nCCDC 1514766-1514769 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 65, "type": "text", "classification": ["else"], "content": "<p>The authors declare no\ncompeting financial interest.</p>", "clean_text": "The authors declare no competing financial interest.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "11, 12, 13", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>3</sub>(\u03bc-OH)]\u00b7H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub> (<bold>2</bold>)</title><p>Compound <bold>2</bold> was obtained by\nhydrothermal routes through the following procedure: A mixture of\nZnCl<sub>2</sub> (0.068 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole\n(0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 43%, based on Zn.\nAnal. Calcd C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub>: C 21.53, H 1.81, N 25.11. Found: C 21.42, H 1.76, N 25.32.</p><title>Synthesis of {[Zn<sub>2</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>3</bold>)</title><p>A mixture\nof Zn\u00ad(NO<sub>3</sub>)<sub>2</sub>\u00b76\u00ad(H<sub>2</sub>O)\n(0.149 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole (0.113 g,\n1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 55%, based on Zn.\nAnal. Calcd C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub>: C 24.89, H 1.39, N 29.03. Found: C 24.69, H 1.31,\nN 29.24.</p><title>Synthesis of {[Zn<sub>3</sub>(\u03bc-4-NO<sub>2</sub>-pz)<sub>4</sub>(\u03bc-ac)<sub>2</sub>(H<sub>2</sub>O)<sub>2</sub>]}<sub>\n<italic>n</italic>\n</sub> (<bold>4</bold>)</title><p>A mixture of zinc\nacetate (0.092 g, 0.5 mmol), 4-nitro-1<italic>H</italic>-pyrazole\n(0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined\nacid digestion autoclave and heated at 120 \u00b0C under autogenous\npressure. After 12 h of heating, the reaction vessel was slowly cooled\ndown to room temperature during a period of about 3 h. Yellow crystals\nof the compound under study were obtained. Yield: 37%, based on Zn.\nAnal. Calcd C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub>: C 24.06, H 2.27, N 21.05. Found: C 23.96, H 2.21,\nN 21.19.</p>", "clean_text": "Synthesis of {[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n  (2)\n\nCompound 2 was obtained by hydrothermal routes through the following procedure: A mixture of ZnCl2 (0.068 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 43%, based on Zn. Anal. Calcd C9H9N9O8Zn2: C 21.53, H 1.81, N 25.11. Found: C 21.42, H 1.76, N 25.32.\n\nSynthesis of {[Zn2(\u03bc-4-NO2-pz)4]} n  (3)\n\nA mixture of Zn(NO3)2\u22c56(H2O) (0.149 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 55%, based on Zn. Anal. Calcd C12H8N12O8Zn2: C 24.89, H 1.39, N 29.03. Found: C 24.69, H 1.31, N 29.24.\n\nSynthesis of {[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n  (4)\n\nA mixture of zinc acetate (0.092 g, 0.5 mmol), 4-nitro-1H-pyrazole (0.113 g, 1 mmol), and distilled water (10 mL) was sealed in a Teflon-lined acid digestion autoclave and heated at 120 \u00b0C under autogenous pressure. After 12 h of heating, the reaction vessel was slowly cooled down to room temperature during a period of about 3 h. Yellow crystals of the compound under study were obtained. Yield: 37%, based on Zn. Anal. Calcd C16H18N12O14Zn3: C 24.06, H 2.27, N 21.05. Found: C 23.96, H 2.21, N 21.19.", "data": [[{"meta": {"name": "{[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n", "symbol": "2", "chemical formula": "C9H9N9O8Zn2"}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "ZnCl2", "amount": "0.068", "unit": "g"}, {"name": "4-nitro-1H-pyrazole", "amount": "0.113", "unit": "g"}], "solvent": [{"name": "distilled water", "amount": "10", "unit": "mL"}], "reducing agent": [], "surfactant": [], "pressure": "autogenous", "temperature": "120 \u00b0C", "time": "12 h", "heating rate": "", "cooling rate": "3 h"}], "yield": "43%"}, {"meta": {"name": "{[Zn2(\u03bc-4-NO2-pz)4]} n", "symbol": "3", "chemical formula": "C12H8N12O8Zn2"}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "Zn(NO3)2\u22c56(H2O)", "amount": "0.149", "unit": "g"}, {"name": "4-nitro-1H-pyrazole", "amount": "0.113", "unit": "g"}], "solvent": [{"name": "distilled water", "amount": "10", "unit": "mL"}], "reducing agent": [], "surfactant": [], "pressure": "autogenous", "temperature": "120 \u00b0C", "time": "12 h", "heating rate": "", "cooling rate": "3 h"}], "yield": "55%"}, {"meta": {"name": "{[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n", "symbol": "4", "chemical formula": "C16H18N12O14Zn3"}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "zinc acetate", "amount": "0.092", "unit": "g"}, {"name": "4-nitro-1H-pyrazole", "amount": "0.113", "unit": "g"}], "solvent": [{"name": "distilled water", "amount": "10", "unit": "mL"}], "reducing agent": [], "surfactant": [], "pressure": "autogenous", "temperature": "120 \u00b0C", "time": "12 h", "heating rate": "", "cooling rate": "3 h"}], "yield": "37%"}]], "include_properties": ["solvothermal_synthesis"], "intermediate_step": {"text-synthesis-type": "['solvothermal_synthesis']", "text-synthesis-struct": "```JSON\n[\n    {\"meta\":{\"name\":\"{[Zn2(\u03bc-4-NO2-pz)3(\u03bc-OH)]\u22c5H2O} n\", \"symbol\":\"2\", \"chemical formula\":\"C9H9N9O8Zn2\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"ZnCl2\", \"amount\":\"0.068\", \"unit\":\"g\"}, {\"name\":\"4-nitro-1H-pyrazole\", \"amount\":\"0.113\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"distilled water\", \"amount\":\"10\", \"unit\":\"mL\"}], \"reducing agent\":[], \"surfactant\":[], \"pressure\":\"autogenous\", \"temperature\":\"120 \u00b0C\", \"time\":\"12 h\", \"heating rate\":\"\", \"cooling rate\":\"3 h\"}], \"yield\": \"43%\"}, \n    {\"meta\":{\"name\":\"{[Zn2(\u03bc-4-NO2-pz)4]} n\", \"symbol\":\"3\", \"chemical formula\":\"C12H8N12O8Zn2\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"Zn(NO3)2\u22c56(H2O)\", \"amount\":\"0.149\", \"unit\":\"g\"}, {\"name\":\"4-nitro-1H-pyrazole\", \"amount\":\"0.113\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"distilled water\", \"amount\":\"10\", \"unit\":\"mL\"}], \"reducing agent\":[], \"surfactant\":[], \"pressure\":\"autogenous\", \"temperature\":\"120 \u00b0C\", \"time\":\"12 h\", \"heating rate\":\"\", \"cooling rate\":\"3 h\"}], \"yield\": \"55%\"}, \n    {\"meta\":{\"name\":\"{[Zn3(\u03bc-4-NO2-pz)4(\u03bc-ac)2(H2O)2]} n\", \"symbol\":\"4\", \"chemical formula\":\"C16H18N12O14Zn3\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"zinc acetate\", \"amount\":\"0.092\", \"unit\":\"g\"}, {\"name\":\"4-nitro-1H-pyrazole\", \"amount\":\"0.113\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"distilled water\", \"amount\":\"10\", \"unit\":\"mL\"}], \"reducing agent\":[], \"surfactant\":[], \"pressure\":\"autogenous\", \"temperature\":\"120 \u00b0C\", \"time\":\"12 h\", \"heating rate\":\"\", \"cooling rate\":\"3 h\"}], \"yield\": \"37%\"}\n]\n```"}}, {"idx": 54, "type": "text", "classification": "property", "content": "<p>Both\ncoordination complexes (compounds <bold>3</bold> and <bold>4</bold>) show cytotoxicity properties at the conditions assayed\n(0 to 100 \u03bcg/mL) with IC<sub>50</sub> data range between 42\nto 53 \u03bcg/mL, IC<sub>20</sub> data between 15 to 34 \u03bcg/mL,\nand IC<sub>80</sub> data between 73 to 80 \u03bcg/mL.</p>", "clean_text": "Both coordination complexes (compounds 3 and 4) show cytotoxicity properties at the conditions assayed (0 to 100 \u03bcg/mL) with IC50 data range between 42 to 53 \u03bcg/mL, IC20 data between 15 to 34 \u03bcg/mL, and IC80 data between 73 to 80 \u03bcg/mL.", "data": [[[{"meta": {"name": "", "symbol": "3", "chemical formula": ""}, "etc": [{"property name": "cytotoxicity", "value": "42 to 53", "unit": "\u03bcg/mL", "condition": "IC50 data range"}, {"property name": "cytotoxicity", "value": "15 to 34", "unit": "\u03bcg/mL", "condition": "IC20 data range"}, {"property name": "cytotoxicity", "value": "73 to 80", "unit": "\u03bcg/mL", "condition": "IC80 data range"}]}, {"meta": {"name": "", "symbol": "4", "chemical formula": ""}, "etc": [{"property name": "cytotoxicity", "value": "42 to 53", "unit": "\u03bcg/mL", "condition": "IC50 data range"}, {"property name": "cytotoxicity", "value": "15 to 34", "unit": "\u03bcg/mL", "condition": "IC20 data range"}, {"property name": "cytotoxicity", "value": "73 to 80", "unit": "\u03bcg/mL", "condition": "IC80 data range"}]}]]], "include_properties": ["etc"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['etc']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"42 to 53\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC50 data range\"\n            },\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"15 to 34\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC20 data range\"\n            },\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"73 to 80\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC80 data range\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"42 to 53\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC50 data range\"\n            },\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"15 to 34\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC20 data range\"\n            },\n            {\n                \"property name\": \"cytotoxicity\",\n                \"value\": \"73 to 80\",\n                \"unit\": \"\u03bcg/mL\",\n                \"condition\": \"IC80 data range\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 16, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystallographic Data for Compounds <bold>1\u20134</bold>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"5\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">compd</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>2</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>4</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>chem formula</oasis:entry>\n<oasis:entry>C<sub>3</sub>H<sub>3</sub>N<sub>3</sub>O<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub>\n</oasis:entry>\n<oasis:entry>C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC\nnumber</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514767\">1514767</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514768\">1514768</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514769\">1514769</ext-link>\n</oasis:entry>\n<oasis:entry>\n<ext-link ext-link-type=\"ccdc\" xlink:href=\"1514766\">1514766</ext-link>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>M</italic> (g\nmol<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>113.08</oasis:entry>\n<oasis:entry>501.99</oasis:entry>\n<oasis:entry>579.04</oasis:entry>\n<oasis:entry>798.53</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>T</italic> (K)</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n<oasis:entry>100</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst syst</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>triclinic</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic>P</italic>2<sub>1</sub>/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>P</italic>1\u0305</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>8.0288(16)</oasis:entry>\n<oasis:entry>7.2679(3)</oasis:entry>\n<oasis:entry>9.2248(4)</oasis:entry>\n<oasis:entry>18.446(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.6212(19)</oasis:entry>\n<oasis:entry>23.1699(10)</oasis:entry>\n<oasis:entry>10.0991(4)</oasis:entry>\n<oasis:entry>13.740(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>9.906(2)</oasis:entry>\n<oasis:entry>9.9116(4)</oasis:entry>\n<oasis:entry>11.4626(4)</oasis:entry>\n<oasis:entry>10.814(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>74.395(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>79.557(1)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>81.549(3)</oasis:entry>\n<oasis:entry>92.337(2)</oasis:entry>\n<oasis:entry>66.699(1)</oasis:entry>\n<oasis:entry>109.872(5)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c3 (deg)</oasis:entry>\n<oasis:entry>83.255(3)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n<oasis:entry>87.241(1)</oasis:entry>\n<oasis:entry>90</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>726.5(3)</oasis:entry>\n<oasis:entry>1667.69(12)</oasis:entry>\n<oasis:entry>964.21(7)</oasis:entry>\n<oasis:entry>2577.6(17)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Z</oasis:entry>\n<oasis:entry>6</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>2</oasis:entry>\n<oasis:entry>4</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03c1 (g cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.551</oasis:entry>\n<oasis:entry>1.999</oasis:entry>\n<oasis:entry>1.994</oasis:entry>\n<oasis:entry>2.058</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>0.132</oasis:entry>\n<oasis:entry>2.942</oasis:entry>\n<oasis:entry>2.563</oasis:entry>\n<oasis:entry>2.866</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>unique reflections</oasis:entry>\n<oasis:entry>2698</oasis:entry>\n<oasis:entry>45276</oasis:entry>\n<oasis:entry>22084</oasis:entry>\n<oasis:entry>8194</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>(int)</oasis:entry>\n<oasis:entry>0.023</oasis:entry>\n<oasis:entry>0.079</oasis:entry>\n<oasis:entry>0.043</oasis:entry>\n<oasis:entry>0.032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.060</oasis:entry>\n<oasis:entry>1.067</oasis:entry>\n<oasis:entry>1.034</oasis:entry>\n<oasis:entry>1.069</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>1\u00a0[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.054</oasis:entry>\n<oasis:entry>0.034</oasis:entry>\n<oasis:entry>0.028</oasis:entry>\n<oasis:entry>0.032</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>2\u00a0[<italic>I</italic>\u00a0&gt;\u00a02\u03c3(<italic>I</italic>)]<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.132</oasis:entry>\n<oasis:entry>0.062</oasis:entry>\n<oasis:entry>0.058</oasis:entry>\n<oasis:entry>0.074</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>(<italic>F</italic>) = \u2211||<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>||/\u2211|<italic>F</italic>\n<sub>o</sub>|; <italic>wR</italic>(<italic>F</italic>\n<sup>2</sup>) = [\u2211<italic>w</italic>(<italic>F</italic>\n<sub>o</sub>\n<sup>2</sup> \u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>/\u2211<italic>wF</italic>\n<sup>4</sup>]<sup>1/2</sup>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Crystallographic Data for Compounds 1\u20134\n\n| compd | 1 | 2 | 3 | 4 |\n|-------|---|---|---|---|\n| chem formula | C<sub>3</sub>H<sub>3</sub>N<sub>3</sub>O<sub>2</sub> | C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub> | C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub> | C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub> |\n| CCDC number | [1514767](1514767) | [1514768](1514768) | [1514769](1514769) | [1514766](1514766) |\n| M (g mol<sup>\u20131</sup>) | 113.08 | 501.99 | 579.04 | 798.53 |\n| T (K) | 100 | 100 | 100 | 100 |\n| cryst syst | triclinic | monoclinic | triclinic | monoclinic |\n| space group | P1\u0305 | P2<sub>1</sub>/c | P1\u0305 | C2/c |\n| a (\u00c5) | 8.0288(16) | 7.2679(3) | 9.2248(4) | 18.446(5) |\n| b (\u00c5) | 9.6212(19) | 23.1699(10) | 10.0991(4) | 13.740(5) |\n| c (\u00c5) | 9.906(2) | 9.9116(4) | 11.4626(4) | 10.814(5) |\n| \u03b1 (deg) | 74.395(3) | 90 | 79.557(1) | 90 |\n| \u03b2 (deg) | 81.549(3) | 92.337(2) | 66.699(1) | 109.872(5) |\n| \u03c3 (deg) | 83.255(3) | 90 | 87.241(1) | 90 |\n| V (\u00c5<sup>3</sup>) | 726.5(3) | 1667.69(12) | 964.21(7) | 2577.6(17) |\n| Z | 6 | 4 | 2 | 4 |\n| \u03c1 (g cm<sup>\u20133</sup>) | 1.551 | 1.999 | 1.994 | 2.058 |\n| \u03bc (mm<sup>\u20131</sup>) | 0.132 | 2.942 | 2.563 | 2.866 |\n| unique reflections | 2698 | 45276 | 22084 | 8194 |\n| R(int) | 0.023 | 0.079 | 0.043 | 0.032 |\n| GOF on F<sup>2</sup> | 1.060 | 1.067 | 1.034 | 1.069 |\n| R1\u00a0[I\u00a0&gt;\u00a02\u03c3(I)][^a] | 0.054 | 0.034 | 0.028 | 0.032 |\n| wR2\u00a0[I\u00a0&gt;\u00a02\u03c3(I)][^a] | 0.132 | 0.062 | 0.058 | 0.074 |\n\n[^a]: R(F) = \u2211||F<sub>o</sub>| \u2013 |F<sub>c</sub>||/\u2211|F<sub>o</sub>|; wR(F<sup>2</sup>) = [\u2211w(F<sub>o</sub><sup>2</sup> \u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211wF<sup>4</sup>]<sup>1/2</sup>.", "data": [[{"meta": {"name": "", "symbol": "1", "chemical formula": "C\u2083H\u2083N\u2083O\u2082"}, "chemical formula weight": [{"value": "113.08", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "8.0288(16)", "b": "9.6212(19)", "c": "9.906(2)", "alpha": "74.395(3)", "beta": "81.549(3)", "gamma": "83.255(3)"}, "condition": ""}], "cell volume": [{"value": "726.5(3)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.551", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "2", "chemical formula": "C\u2089H\u2089N\u2089O\u2088Zn\u2082"}, "chemical formula weight": [{"value": "501.99", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "P2\u2081/c", "condition": ""}], "lattice parameters": [{"value": {"a": "7.2679(3)", "b": "23.1699(10)", "c": "9.9116(4)", "alpha": "90", "beta": "92.337(2)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "1667.69(12)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.999", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "3", "chemical formula": "C\u2081\u2082H\u2088N\u2081\u2082O\u2088Zn\u2082"}, "chemical formula weight": [{"value": "579.04", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "triclinic", "condition": ""}], "space group": [{"value": "P1\u0305", "condition": ""}], "lattice parameters": [{"value": {"a": "9.2248(4)", "b": "10.0991(4)", "c": "11.4626(4)", "alpha": "79.557(1)", "beta": "66.699(1)", "gamma": "87.241(1)"}, "condition": ""}], "cell volume": [{"value": "964.21(7)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.994", "unit": "g/cm^3", "condition": ""}]}, {"meta": {"name": "", "symbol": "4", "chemical formula": "C\u2081\u2086H\u2081\u2088N\u2081\u2082O\u2081\u2084Zn\u2083"}, "chemical formula weight": [{"value": "798.53", "unit": "g/mol", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "C2/c", "condition": ""}], "lattice parameters": [{"value": {"a": "18.446(5)", "b": "13.740(5)", "c": "10.814(5)", "alpha": "90", "beta": "109.872(5)", "gamma": "90"}, "condition": ""}], "cell volume": [{"value": "2577.6(17)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "2.058", "unit": "g/cm^3", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Crystallographic Data for Compounds 1\u20134\n\n| compd | 1 | 2 | 3 | 4 |\n|-------|---|---|---|---|\n| chem formula | C<sub>3</sub>H<sub>3</sub>N<sub>3</sub>O<sub>2</sub> | C<sub>9</sub>H<sub>9</sub>N<sub>9</sub>O<sub>8</sub>Zn<sub>2</sub> | C<sub>12</sub>H<sub>8</sub>N<sub>12</sub>O<sub>8</sub>Zn<sub>2</sub> | C<sub>16</sub>H<sub>18</sub>N<sub>12</sub>O<sub>14</sub>Zn<sub>3</sub> |\n| CCDC number | [1514767](1514767) | [1514768](1514768) | [1514769](1514769) | [1514766](1514766) |\n| M (g mol<sup>\u20131</sup>) | 113.08 | 501.99 | 579.04 | 798.53 |\n| T (K) | 100 | 100 | 100 | 100 |\n| cryst syst | triclinic | monoclinic | triclinic | monoclinic |\n| space group | P1\u0305 | P2<sub>1</sub>/c | P1\u0305 | C2/c |\n| a (\u00c5) | 8.0288(16) | 7.2679(3) | 9.2248(4) | 18.446(5) |\n| b (\u00c5) | 9.6212(19) | 23.1699(10) | 10.0991(4) | 13.740(5) |\n| c (\u00c5) | 9.906(2) | 9.9116(4) | 11.4626(4) | 10.814(5) |\n| \u03b1 (deg) | 74.395(3) | 90 | 79.557(1) | 90 |\n| \u03b2 (deg) | 81.549(3) | 92.337(2) | 66.699(1) | 109.872(5) |\n| \u03c3 (deg) | 83.255(3) | 90 | 87.241(1) | 90 |\n| V (\u00c5<sup>3</sup>) | 726.5(3) | 1667.69(12) | 964.21(7) | 2577.6(17) |\n| Z | 6 | 4 | 2 | 4 |\n| \u03c1 (g cm<sup>\u20133</sup>) | 1.551 | 1.999 | 1.994 | 2.058 |\n| \u03bc (mm<sup>\u20131</sup>) | 0.132 | 2.942 | 2.563 | 2.866 |\n| unique reflections | 2698 | 45276 | 22084 | 8194 |\n| R(int) | 0.023 | 0.079 | 0.043 | 0.032 |\n| GOF on F<sup>2</sup> | 1.060 | 1.067 | 1.034 | 1.069 |\n| R1\u00a0[I\u00a0&gt;\u00a02\u03c3(I)][^a] | 0.054 | 0.034 | 0.028 | 0.032 |\n| wR2\u00a0[I\u00a0&gt;\u00a02\u03c3(I)][^a] | 0.132 | 0.062 | 0.058 | 0.074 |\n\n[^a]: R(F) = \u2211||F<sub>o</sub>| \u2013 |F<sub>c</sub>||/\u2211|F<sub>o</sub>|; wR(F<sup>2</sup>) = [\u2211w(F<sub>o</sub><sup>2</sup> \u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>/\u2211wF<sup>4</sup>]<sup>1/2</sup>.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"1\",\n            \"chemical formula\": \"C\u2083H\u2083N\u2083O\u2082\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"113.08\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"8.0288(16)\",\n                    \"b\": \"9.6212(19)\",\n                    \"c\": \"9.906(2)\",\n                    \"alpha\": \"74.395(3)\",\n                    \"beta\": \"81.549(3)\",\n                    \"gamma\": \"83.255(3)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"726.5(3)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.551\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"2\",\n            \"chemical formula\": \"C\u2089H\u2089N\u2089O\u2088Zn\u2082\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"501.99\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P2\u2081/c\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"7.2679(3)\",\n                    \"b\": \"23.1699(10)\",\n                    \"c\": \"9.9116(4)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"92.337(2)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1667.69(12)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.999\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"C\u2081\u2082H\u2088N\u2081\u2082O\u2088Zn\u2082\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"579.04\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"triclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"P1\u0305\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"9.2248(4)\",\n                    \"b\": \"10.0991(4)\",\n                    \"c\": \"11.4626(4)\",\n                    \"alpha\": \"79.557(1)\",\n                    \"beta\": \"66.699(1)\",\n                    \"gamma\": \"87.241(1)\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"964.21(7)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.994\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"C\u2081\u2086H\u2081\u2088N\u2081\u2082O\u2081\u2084Zn\u2083\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"798.53\",\n                \"unit\": \"g/mol\",\n                \"condition\": \"\",\n            }\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"C2/c\",\n                \"condition\": \"\",\n            }\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"18.446(5)\",\n                    \"b\": \"13.740(5)\",\n                    \"c\": \"10.814(5)\",\n                    \"alpha\": \"90\",\n                    \"beta\": \"109.872(5)\",\n                    \"gamma\": \"90\"\n                },\n                \"condition\": \"\",\n            }\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"2577.6(17)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            }\n        ],\n        \"density\": [\n            {\n                \"value\": \"2.058\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            }\n        ]\n    }\n]\n```"}}, {"idx": 30, "type": "table", "classification": ["Bond & Angle"], "content": "<table-wrap id=\"tbl2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>2</bold>\n<xref ref-type=\"table-fn\" rid=\"t2fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.013(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>1.987(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1B</oasis:entry>\n<oasis:entry>1.991(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1C</oasis:entry>\n<oasis:entry>1.986(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2C(i)</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1</oasis:entry>\n<oasis:entry>1.927(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O1(ii)</oasis:entry>\n<oasis:entry>1.992(2)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t2fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic>, \u2212<italic>y</italic>, \u2212<italic>z</italic>; (ii) \u2212<italic>x</italic> \u2013 1, \u2212<italic>y</italic>, \u2212<italic>z</italic>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 2. Selected Bond Lengths for Compound 2[^a]\n\n|          |          |          |          |\n|----------|----------|----------|----------|\n| Zn1\u2013N1A  | 2.013(2) | Zn2\u2013N2A  | 1.987(2) |\n| Zn1\u2013N1B  | 1.991(2) | Zn2\u2013N2B  | 1.997(2) |\n| Zn1\u2013N1C  | 1.986(2) | Zn2\u2013N2C(i) | 1.997(2) |\n| Zn1\u2013O1   | 1.927(2) | Zn2\u2013O1(ii) | 1.992(2) |\n\n[^a]: Symmetries: (i) \u2212x, \u2212y, \u2212z; (ii) \u2212x \u2013 1, \u2212y, \u2212z.", "data": [["Bond & Angle type of table is not target"]], "include_properties": null, "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 2. Selected Bond Lengths for Compound 2[^a]\n\n|          |          |          |          |\n|----------|----------|----------|----------|\n| Zn1\u2013N1A  | 2.013(2) | Zn2\u2013N2A  | 1.987(2) |\n| Zn1\u2013N1B  | 1.991(2) | Zn2\u2013N2B  | 1.997(2) |\n| Zn1\u2013N1C  | 1.986(2) | Zn2\u2013N2C(i) | 1.997(2) |\n| Zn1\u2013O1   | 1.927(2) | Zn2\u2013O1(ii) | 1.992(2) |\n\n[^a]: Symmetries: (i) \u2212x, \u2212y, \u2212z; (ii) \u2212x \u2013 1, \u2212y, \u2212z.\n<END>", "table-categorize": "Bond & Angle"}}, {"idx": 36, "type": "table", "classification": ["Bond & Angle"], "content": "<table-wrap id=\"tbl3\" position=\"float\">\n<label>3</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>3</bold>\n<xref ref-type=\"table-fn\" rid=\"t3fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.010(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N1D</oasis:entry>\n<oasis:entry>1.987(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1B</oasis:entry>\n<oasis:entry>1.997(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>1.986(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1C</oasis:entry>\n<oasis:entry>2.000(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N2C(i)</oasis:entry>\n<oasis:entry>2.009(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2D(ii)</oasis:entry>\n<oasis:entry>1.999(2)</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t3fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic> + 2, \u2212<italic>y</italic> + 1, \u2212<italic>z</italic> + 1; (ii) \u2212<italic>x</italic> + 2, \u2212<italic>y</italic>, \u2212<italic>z</italic> + 2.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 3. Selected Bond Lengths for Compound 3[^a]\n\n|       |       |       |       |\n|-------|-------|-------|-------|\n| Zn1\u2013N1A | 2.010(2) | Zn2\u2013N1D | 1.987(2) |\n| Zn1\u2013N1B | 1.997(2) | Zn2\u2013N2A | 1.986(2) |\n| Zn1\u2013N1C | 2.000(2) | Zn2\u2013N2B | 2.036(2) |\n| Zn1\u2013N2C(i) | 2.009(2) | Zn2\u2013N2D(ii) | 1.999(2) |\n\n[^a]: Symmetries: (i) \u2212x + 2, \u2212y + 1, \u2212z + 1; (ii) \u2212x + 2, \u2212y, \u2212z + 2.", "data": [["Bond & Angle type of table is not target"]], "include_properties": null, "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 3. Selected Bond Lengths for Compound 3[^a]\n\n|       |       |       |       |\n|-------|-------|-------|-------|\n| Zn1\u2013N1A | 2.010(2) | Zn2\u2013N1D | 1.987(2) |\n| Zn1\u2013N1B | 1.997(2) | Zn2\u2013N2A | 1.986(2) |\n| Zn1\u2013N1C | 2.000(2) | Zn2\u2013N2B | 2.036(2) |\n| Zn1\u2013N2C(i) | 2.009(2) | Zn2\u2013N2D(ii) | 1.999(2) |\n\n[^a]: Symmetries: (i) \u2212x + 2, \u2212y + 1, \u2212z + 1; (ii) \u2212x + 2, \u2212y, \u2212z + 2.\n<END>", "table-categorize": "Bond & Angle"}}, {"idx": 42, "type": "table", "classification": ["Bond & Angle"], "content": "<table-wrap id=\"tbl4\" position=\"float\">\n<label>4</label>\n<caption>\n<title>Selected Bond Lengths for Compound <bold>4</bold>\n<xref ref-type=\"table-fn\" rid=\"t4fn1\"></xref>\n</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A</oasis:entry>\n<oasis:entry>2.023(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2A</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013N1A(i)</oasis:entry>\n<oasis:entry>2.023(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N1B</oasis:entry>\n<oasis:entry>2.010(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O11C</oasis:entry>\n<oasis:entry>2.151(2)</oasis:entry>\n<oasis:entry>Zn2\u2013N2B(ii)</oasis:entry>\n<oasis:entry>2.036(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O11C(i)</oasis:entry>\n<oasis:entry>2.151(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O11C(i)</oasis:entry>\n<oasis:entry>2.295(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1w</oasis:entry>\n<oasis:entry>2.242(2)</oasis:entry>\n<oasis:entry>Zn2\u2013O12C(i)</oasis:entry>\n<oasis:entry>2.063(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Zn1\u2013O1w(i)</oasis:entry>\n<oasis:entry>2.242(2)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t4fn1\">\n<label>a</label>\n<p>Symmetries: (i) \u2212<italic>x</italic> + 1/2, \u2212<italic>y</italic> + 1/2, \u2212<italic>z</italic> + 1; (ii) \u2212<italic>x</italic> + 1/2, \u2212<italic>y</italic> + 1/2, \u2212<italic>z</italic>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 4. Selected Bond Lengths for Compound 4[^a]\n\n|          |          |          |          |\n|----------|----------|----------|----------|\n| Zn1\u2013N1A  | 2.023(2) | Zn2\u2013N2A  | 2.036(2) |\n| Zn1\u2013N1A(i) | 2.023(2) | Zn2\u2013N1B | 2.010(2) |\n| Zn1\u2013O11C | 2.151(2) | Zn2\u2013N2B(ii) | 2.036(2) |\n| Zn1\u2013O11C(i) | 2.151(2) | Zn2\u2013O11C(i) | 2.295(2) |\n| Zn1\u2013O1w | 2.242(2) | Zn2\u2013O12C(i) | 2.063(2) |\n| Zn1\u2013O1w(i) | 2.242(2) |          |          |\n\n[^a]: Symmetries: (i) \u2212x + 1/2, \u2212y + 1/2, \u2212z + 1; (ii) \u2212x + 1/2, \u2212y + 1/2, \u2212z.", "data": [["Bond & Angle type of table is not target"]], "include_properties": null, "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 4. Selected Bond Lengths for Compound 4[^a]\n\n|          |          |          |          |\n|----------|----------|----------|----------|\n| Zn1\u2013N1A  | 2.023(2) | Zn2\u2013N2A  | 2.036(2) |\n| Zn1\u2013N1A(i) | 2.023(2) | Zn2\u2013N1B | 2.010(2) |\n| Zn1\u2013O11C | 2.151(2) | Zn2\u2013N2B(ii) | 2.036(2) |\n| Zn1\u2013O11C(i) | 2.151(2) | Zn2\u2013O11C(i) | 2.295(2) |\n| Zn1\u2013O1w | 2.242(2) | Zn2\u2013O12C(i) | 2.063(2) |\n| Zn1\u2013O1w(i) | 2.242(2) |          |          |\n\n[^a]: Symmetries: (i) \u2212x + 1/2, \u2212y + 1/2, \u2212z + 1; (ii) \u2212x + 1/2, \u2212y + 1/2, \u2212z.\n<END>", "table-categorize": "Bond & Angle"}}, {"idx": 53, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl5\" position=\"float\">\n<label>5</label>\n<caption>\n<title>Growth-Inhibitory Effects of Compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> on the\nThree Cancer Cell Lines</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"8\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col5\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col6\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col7\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col8\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">cell line</oasis:entry>\n<oasis:entry align=\"center\">compd\u00a0#</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>20</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/IC of compound</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>50</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/ IC of compound</oasis:entry>\n<oasis:entry align=\"center\">IC<sub>80</sub>\n</oasis:entry>\n<oasis:entry align=\"center\">IC Lig<sup>b</sup>/IC of compound</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>HT29</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>56.5\u00a0\u00b1\u00a08.0</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>97.6\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>216.5\u00a0\u00b1\u00a016.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>23.2\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>46.7\u00a0\u00b1\u00a08.8</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>77.3\u00a0\u00b1\u00a013.7</oasis:entry>\n<oasis:entry>2.8</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>18.8\u00a0\u00b1\u00a09.3</oasis:entry>\n<oasis:entry>3.0</oasis:entry>\n<oasis:entry>41.8\u00a0\u00b1\u00a015.0</oasis:entry>\n<oasis:entry>2.3</oasis:entry>\n<oasis:entry>75.2\u00a0\u00b1\u00a015.8</oasis:entry>\n<oasis:entry>2.9</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>Hep-G2</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>50.9\u00a0\u00b1\u00a016.4</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>210.6\u00a0\u00b1\u00a016.1</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>521.0\u00a0\u00b1\u00a015.9</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>17.4\u00a0\u00b1\u00a03.9</oasis:entry>\n<oasis:entry>2.9</oasis:entry>\n<oasis:entry>45.4\u00a0\u00b1\u00a01.9</oasis:entry>\n<oasis:entry>4.6</oasis:entry>\n<oasis:entry>78.0\u00a0\u00b1\u00a00.2</oasis:entry>\n<oasis:entry>6.7</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>15.1\u00a0\u00b1\u00a02.6</oasis:entry>\n<oasis:entry>3.4</oasis:entry>\n<oasis:entry>45.8\u00a0\u00b1\u00a02.7</oasis:entry>\n<oasis:entry>4.6</oasis:entry>\n<oasis:entry>80.5\u00a0\u00b1\u00a01.6</oasis:entry>\n<oasis:entry>6.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>B16-F10</oasis:entry>\n<oasis:entry>\n<bold>1</bold>\n</oasis:entry>\n<oasis:entry>82.7\u00a0\u00b1\u00a011.5</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>101.8\u00a0\u00b1\u00a01.1</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n<oasis:entry>113.6\u00a0\u00b1\u00a06.3</oasis:entry>\n<oasis:entry>1.0</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>3</bold>\n</oasis:entry>\n<oasis:entry>33.9\u00a0\u00b1\u00a06.3</oasis:entry>\n<oasis:entry>2.4</oasis:entry>\n<oasis:entry>52.6\u00a0\u00b1\u00a01.4</oasis:entry>\n<oasis:entry>1.9</oasis:entry>\n<oasis:entry>73.4\u00a0\u00b1\u00a02.4</oasis:entry>\n<oasis:entry>1.5</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\n<bold>4</bold>\n</oasis:entry>\n<oasis:entry>15.9\u00a0\u00b1\u00a06.9</oasis:entry>\n<oasis:entry>5.2</oasis:entry>\n<oasis:entry>47.8\u00a0\u00b1\u00a04.9</oasis:entry>\n<oasis:entry>2.1</oasis:entry>\n<oasis:entry>78.3\u00a0\u00b1\u00a04.1</oasis:entry>\n<oasis:entry>1.5</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n</table-wrap>", "clean_text": "Table 5. Growth-Inhibitory Effects of Compounds 1, 2, 3, and 4 on the Three Cancer Cell Lines\n\n| cell line | compd\u00a0# | IC<sub>20</sub> | IC Lig<sup>b</sup>/IC of compound | IC<sub>50</sub> | IC Lig<sup>b</sup>/ IC of compound | IC<sub>80</sub> | IC Lig<sup>b</sup>/IC of compound |\n|-----------|--------|----------------|-----------------------------------|----------------|-----------------------------------|----------------|-----------------------------------|\n| HT29      | 1      | 56.5\u00a0\u00b1\u00a08.0      | 1.0                               | 97.6\u00a0\u00b1\u00a04.9     | 1.0                               | 216.5\u00a0\u00b1\u00a016.9   | 1.0                               |\n|           | 3      | 23.2\u00a0\u00b1\u00a04.9      | 2.4                               | 46.7\u00a0\u00b1\u00a08.8     | 2.1                               | 77.3\u00a0\u00b1\u00a013.7    | 2.8                               |\n|           | 4      | 18.8\u00a0\u00b1\u00a09.3      | 3.0                               | 41.8\u00a0\u00b1\u00a015.0    | 2.3                               | 75.2\u00a0\u00b1\u00a015.8    | 2.9                               |\n| Hep-G2    | 1      | 50.9\u00a0\u00b1\u00a016.4     | 1.0                               | 210.6\u00a0\u00b1\u00a016.1   | 1.0                               | 521.0\u00a0\u00b1\u00a015.9   | 1.0                               |\n|           | 3      | 17.4\u00a0\u00b1\u00a03.9      | 2.9                               | 45.4\u00a0\u00b1\u00a01.9     | 4.6                               | 78.0\u00a0\u00b1\u00a00.2     | 6.7                               |\n|           | 4      | 15.1\u00a0\u00b1\u00a02.6      | 3.4                               | 45.8\u00a0\u00b1\u00a02.7     | 4.6                               | 80.5\u00a0\u00b1\u00a01.6     | 6.5                               |\n| B16-F10   | 1      | 82.7\u00a0\u00b1\u00a011.5     | 1.0                               | 101.8\u00a0\u00b1\u00a01.1    | 1.0                               | 113.6\u00a0\u00b1\u00a06.3   | 1.0                               |\n|           | 3      | 33.9\u00a0\u00b1\u00a06.3      | 2.4                               | 52.6\u00a0\u00b1\u00a01.4     | 1.9                               | 73.4\u00a0\u00b1\u00a02.4     | 1.5                               |\n|           | 4      | 15.9\u00a0\u00b1\u00a06.9      | 5.2                               | 47.8\u00a0\u00b1\u00a04.9     | 2.1                               | 78.3\u00a0\u00b1\u00a04.1     | 1.5                               |", "data": [[{"meta": {"name": "HT29", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC20", "compound number": "1", "value": "56.5 \u00b1 8.0", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "1", "value": "97.6 \u00b1 4.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "1", "value": "216.5 \u00b1 16.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "3", "value": "23.2 \u00b1 4.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "2.4", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "3", "value": "46.7 \u00b1 8.8", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "2.1", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "3", "value": "77.3 \u00b1 13.7", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "2.8", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "4", "value": "18.8 \u00b1 9.3", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "3.0", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "4", "value": "41.8 \u00b1 15.0", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "2.3", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "4", "value": "75.2 \u00b1 15.8", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "2.9", "unit": "", "condition": ""}]}, {"meta": {"name": "Hep-G2", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC20", "compound number": "1", "value": "50.9 \u00b1 16.4", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "1", "value": "210.6 \u00b1 16.1", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "1", "value": "521.0 \u00b1 15.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "3", "value": "17.4 \u00b1 3.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "2.9", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "3", "value": "45.4 \u00b1 1.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "4.6", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "3", "value": "78.0 \u00b1 0.2", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "6.7", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "4", "value": "15.1 \u00b1 2.6", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "3.4", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "4", "value": "45.8 \u00b1 2.7", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "4.6", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "4", "value": "80.5 \u00b1 1.6", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "6.5", "unit": "", "condition": ""}]}, {"meta": {"name": "B16-F10", "symbol": "", "chemical formula": ""}, "etc": [{"property name": "IC20", "compound number": "1", "value": "82.7 \u00b1 11.5", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "1", "value": "101.8 \u00b1 1.1", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "1", "value": "113.6 \u00b1 6.3", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "1", "value": "1.0", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "3", "value": "33.9 \u00b1 6.3", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "2.4", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "3", "value": "52.6 \u00b1 1.4", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "1.9", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "3", "value": "73.4 \u00b1 2.4", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "3", "value": "1.5", "unit": "", "condition": ""}, {"property name": "IC20", "compound number": "4", "value": "15.9 \u00b1 6.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "5.2", "unit": "", "condition": ""}, {"property name": "IC50", "compound number": "4", "value": "47.8 \u00b1 4.9", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "2.1", "unit": "", "condition": ""}, {"property name": "IC80", "compound number": "4", "value": "78.3 \u00b1 4.1", "unit": "", "condition": ""}, {"property name": "IC Ligb/IC of compound", "compound number": "4", "value": "1.5", "unit": "", "condition": ""}]}]], "include_properties": ["etc"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 5. Growth-Inhibitory Effects of Compounds 1, 2, 3, and 4 on the Three Cancer Cell Lines\n\n| cell line | compd\u00a0# | IC<sub>20</sub> | IC Lig<sup>b</sup>/IC of compound | IC<sub>50</sub> | IC Lig<sup>b</sup>/ IC of compound | IC<sub>80</sub> | IC Lig<sup>b</sup>/IC of compound |\n|-----------|--------|----------------|-----------------------------------|----------------|-----------------------------------|----------------|-----------------------------------|\n| HT29      | 1      | 56.5\u00a0\u00b1\u00a08.0      | 1.0                               | 97.6\u00a0\u00b1\u00a04.9     | 1.0                               | 216.5\u00a0\u00b1\u00a016.9   | 1.0                               |\n|           | 3      | 23.2\u00a0\u00b1\u00a04.9      | 2.4                               | 46.7\u00a0\u00b1\u00a08.8     | 2.1                               | 77.3\u00a0\u00b1\u00a013.7    | 2.8                               |\n|           | 4      | 18.8\u00a0\u00b1\u00a09.3      | 3.0                               | 41.8\u00a0\u00b1\u00a015.0    | 2.3                               | 75.2\u00a0\u00b1\u00a015.8    | 2.9                               |\n| Hep-G2    | 1      | 50.9\u00a0\u00b1\u00a016.4     | 1.0                               | 210.6\u00a0\u00b1\u00a016.1   | 1.0                               | 521.0\u00a0\u00b1\u00a015.9   | 1.0                               |\n|           | 3      | 17.4\u00a0\u00b1\u00a03.9      | 2.9                               | 45.4\u00a0\u00b1\u00a01.9     | 4.6                               | 78.0\u00a0\u00b1\u00a00.2     | 6.7                               |\n|           | 4      | 15.1\u00a0\u00b1\u00a02.6      | 3.4                               | 45.8\u00a0\u00b1\u00a02.7     | 4.6                               | 80.5\u00a0\u00b1\u00a01.6     | 6.5                               |\n| B16-F10   | 1      | 82.7\u00a0\u00b1\u00a011.5     | 1.0                               | 101.8\u00a0\u00b1\u00a01.1    | 1.0                               | 113.6\u00a0\u00b1\u00a06.3   | 1.0                               |\n|           | 3      | 33.9\u00a0\u00b1\u00a06.3      | 2.4                               | 52.6\u00a0\u00b1\u00a01.4     | 1.9                               | 73.4\u00a0\u00b1\u00a02.4     | 1.5                               |\n|           | 4      | 15.9\u00a0\u00b1\u00a06.9      | 5.2                               | 47.8\u00a0\u00b1\u00a04.9     | 2.1                               | 78.3\u00a0\u00b1\u00a04.1     | 1.5                               |\n<END>", "table-categorize": "Property", "table-property-type": "['etc']", "table-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"HT29\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"1\",\n                \"value\": \"56.5 \u00b1 8.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"1\",\n                \"value\": \"97.6 \u00b1 4.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"1\",\n                \"value\": \"216.5 \u00b1 16.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"3\",\n                \"value\": \"23.2 \u00b1 4.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"2.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"3\",\n                \"value\": \"46.7 \u00b1 8.8\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"2.1\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"3\",\n                \"value\": \"77.3 \u00b1 13.7\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"2.8\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"4\",\n                \"value\": \"18.8 \u00b1 9.3\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"3.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"4\",\n                \"value\": \"41.8 \u00b1 15.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"2.3\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"4\",\n                \"value\": \"75.2 \u00b1 15.8\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"2.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Hep-G2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"1\",\n                \"value\": \"50.9 \u00b1 16.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"1\",\n                \"value\": \"210.6 \u00b1 16.1\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"1\",\n                \"value\": \"521.0 \u00b1 15.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"3\",\n                \"value\": \"17.4 \u00b1 3.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"2.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"3\",\n                \"value\": \"45.4 \u00b1 1.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"4.6\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"3\",\n                \"value\": \"78.0 \u00b1 0.2\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"6.7\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"4\",\n                \"value\": \"15.1 \u00b1 2.6\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"3.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"4\",\n                \"value\": \"45.8 \u00b1 2.7\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"4.6\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"4\",\n                \"value\": \"80.5 \u00b1 1.6\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"6.5\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"B16-F10\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"1\",\n                \"value\": \"82.7 \u00b1 11.5\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"1\",\n                \"value\": \"101.8 \u00b1 1.1\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"1\",\n                \"value\": \"113.6 \u00b1 6.3\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"1\",\n                \"value\": \"1.0\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"3\",\n                \"value\": \"33.9 \u00b1 6.3\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"2.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"3\",\n                \"value\": \"52.6 \u00b1 1.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"1.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"3\",\n                \"value\": \"73.4 \u00b1 2.4\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"3\",\n                \"value\": \"1.5\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC20\",\n                \"compound number\": \"4\",\n                \"value\": \"15.9 \u00b1 6.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"5.2\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC50\",\n                \"compound number\": \"4\",\n                \"value\": \"47.8 \u00b1 4.9\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"2.1\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC80\",\n                \"compound number\": \"4\",\n                \"value\": \"78.3 \u00b1 4.1\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            },\n            {\n                \"property name\": \"IC Ligb/IC of compound\",\n                \"compound number\": \"4\",\n                \"value\": \"1.5\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 4, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"schI\" position=\"float\">\n<label>1</label>\n<caption>\n<title>4-Nitro-1<italic>H</italic>-pyrazole\n(Left) and the Two Different\nCoordination Modes Presented by This Linker (Right: Modes <italic>a</italic> and <italic>b</italic>)</title>\n</caption>\n<graphic id=\"GRAPHIC-d7e405-autogenerated\" position=\"float\" xlink:href=\"cg-2017-01443m_0010.tif\"></graphic>\n</fig>", "clean_text": " 1  4-Nitro-1H-pyrazole (Left) and the Two Different Coordination Modes Presented by This Linker (Right: Modes a and b)   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Excerpt of\nthe supramolecular layer of compound <bold>1</bold> showing\nhydrogen bonding interactions within the central trimer and with neighboring\nones. Strong N\u2013H\u00b7\u00b7\u00b7N (thick dashed orange line)\nand weak C\u2013H\u00b7\u00b7\u00b7O (thine dashed orange line)\ninteractions are drawn.</p>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"cg-2017-01443m_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Excerpt of the supramolecular layer of compound 1 showing hydrogen bonding interactions within the central trimer and with neighboring ones. Strong N-H\u22c5\u22c5\u22c5N (thick dashed orange line) and weak C-H\u22c5\u22c5\u22c5O (thine dashed orange line) interactions are drawn.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 29, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Double 1D chains of compound <bold>2</bold> showing coordination\nenvironments of Zn1 and Zn2 and \u03c0\u2013\u03c0 interactions\namong 4-NO<sub>2</sub>-pz ligands (double dashed orange lines). Color\ncoding: C = gray, H = pink, N = blue, O = red, M = green.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"cg-2017-01443m_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Double 1D chains of compound 2 showing coordination environments of Zn1 and Zn2 and \u03c0-\u03c0 interactions among 4-NO2-pz ligands (double dashed orange lines). Color coding: C = gray, H = pink, N = blue, O = red, M = green.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Packing of chains in <bold>2</bold> along crystallographic <italic>a</italic> axis. Hydrogen\nbonding scheme is detailed in the right\nside.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"cg-2017-01443m_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Packing of chains in 2 along crystallographic a axis. Hydrogen bonding scheme is detailed in the right side.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 35, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>One-dimensional chain of <bold>3</bold> established from\nthe fusion\nof dimeric cores together with tetrahedral coordination environments.\nNumbering scheme for 4-NO<sub>2</sub>-pz ligands is shown.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"cg-2017-01443m_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  One-dimensional chain of 3 established from the fusion of dimeric cores together with tetrahedral coordination environments. Numbering scheme for 4-NO2-pz ligands is shown.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 39, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>Crystal building of compound <bold>3</bold> detailing\na summary\nof supramolecular interactions among 1D chains.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"cg-2017-01443m_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  Crystal building of compound 3 detailing a summary of supramolecular interactions among 1D chains.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 41, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>Coordination environments of Zn1 and Zn2 atoms together with the\ncorrugated chain of compound <bold>4</bold>.</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"cg-2017-01443m_0006.tif\"></graphic>\n</fig>", "clean_text": " 6  Coordination environments of Zn1 and Zn2 atoms together with the corrugated chain of compound 4.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 44, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>Packing of compound <bold>4</bold> showing supramolecular interactions\noccurring among corrugated chains.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"cg-2017-01443m_0007.tif\"></graphic>\n</fig>", "clean_text": " 7  Packing of compound 4 showing supramolecular interactions occurring among corrugated chains.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 52, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>Effects of compounds <bold>1</bold>, <bold>3</bold>, and <bold>4</bold>, on the viability of\nB16-F10, HT29, and HepG2 cancer cells,\nafter treatment with the compounds for 72 h in a range of 0 to 100\n\u03bcg/mL, each point represents the mean value \u00b1 SD of at\nleast two independent experiments performed in triplicate.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"cg-2017-01443m_0008.tif\"></graphic>\n</fig>", "clean_text": " 8  Effects of compounds 1, 3, and 4, on the viability of B16-F10, HT29, and HepG2 cancer cells, after treatment with the compounds for 72 h in a range of 0 to 100 \u03bcg/mL, each point represents the mean value \u00b1 SD of at least two independent experiments performed in triplicate.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 61, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig9\" position=\"float\">\n<label>9</label>\n<caption>\n<p>Growth-inhibitory\neffects (IC<sub>20</sub>, IC<sub>50</sub>, and\nIC<sub>80</sub>, \u03bcg/mL) of compounds <bold>1</bold>, <bold>2</bold>, <bold>3</bold>, and <bold>4</bold> on the three cancer cell lines.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"cg-2017-01443m_0009.tif\"></graphic>\n</fig>", "clean_text": " 9  Growth-inhibitory effects (IC20, IC50, and IC80, \u03bcg/mL) of compounds 1, 2, 3, and 4 on the three cancer cell lines.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/acs.cgd.7b01443", "title": "\nModulating Anticancer Potential by Modifying the Structural\nProperties of a Family of Zinc Metal\u2013Organic Chains Based on\n4\u2011Nitro\u20111H\u2011pyrazole\n", "journal": "American Chemical\nSociety", "date": "2017.12", "author_list": ["Ferna\u0301ndez\nBele\u0301n", "Ferna\u0301ndez\nIgnacio", "Cepeda\nJavier", "Medina-O\u2019Donnell\nMarta", "Rufino-Palomares\nEva E.", "Raya-Baro\u0301n\nA\u0301lvaro", "Go\u0301mez-Ruiz\nSantiago", "Pe\u0301rez-Jime\u0301nez\nAmalia", "Lupia\u0301n\u0303ez\nJose\u0301 Antonio", "Reyes-Zurita\nFernando J.", "Rodri\u0301guez-Die\u0301guez\nAntonio"]}}